%PDF-1.4
1 0 obj
<< /Type /Catalog /Pages 2 0 R >>
endobj
2 0 obj
<< /Type /Pages /Kids [ 4 0 R 6 0 R 8 0 R 10 0 R 12 0 R 14 0 R 16 0 R 18 0 R 20 0 R 22 0 R 24 0 R 26 0 R 28 0 R 30 0 R 32 0 R 34 0 R 36 0 R 38 0 R 40 0 R 42 0 R 44 0 R 46 0 R 48 0 R 50 0 R 52 0 R 54 0 R 56 0 R 58 0 R 60 0 R 62 0 R 64 0 R 66 0 R 68 0 R 70 0 R 72 0 R 74 0 R 76 0 R 78 0 R 80 0 R 82 0 R 84 0 R 86 0 R 88 0 R 90 0 R 92 0 R 94 0 R 96 0 R 98 0 R 100 0 R 102 0 R 104 0 R 106 0 R 108 0 R 110 0 R 112 0 R 114 0 R 116 0 R 118 0 R 120 0 R 122 0 R 124 0 R 126 0 R 128 0 R ] /Count 63 >>
endobj
3 0 obj
<< /Length 3089 >>
stream
BT
/F1 10 Tf
72 720 Td
(Exhibit 10.13) Tj
0 -12 Td
() Tj
0 -12 Td
(Confidential Materials omitted and filed separately with the Securities and Exchange) Tj
0 -12 Td
(Commission. Asterisks denote omissions.) Tj
0 -12 Td
() Tj
0 -12 Td
(DATED: OCTOBER 15, 2009) Tj
0 -12 Td
() Tj
0 -12 Td
(PACIRA PHARMACEUTICALS, INC.) Tj
0 -12 Td
() Tj
0 -12 Td
(and) Tj
0 -12 Td
() Tj
0 -12 Td
(EKR THERAPEUTICS, INC.        AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION AND) Tj
0 -12 Td
(MARKETING AGREEMENT) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(THIS AMENDED AND RESTATED STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT \(the) Tj
0 -12 Td
("Agreement"\) is made on October 15, 2009 \(the "Agreement Date"\) and is effective as of the) Tj
0 -12 Td
(Effective Date \(as defined below\), between:   PACIRA PHARMACEUTICALS, INC. \(F/K/A) Tj
0 -12 Td
(SKYEPHARMA, INC.\) a company incorporated in the state of California whose principal place) Tj
0 -12 Td
(of business is 10450 Sciences Center Drive, San Diego, California 92121 USA \("PPI"\); and) Tj
0 -12 Td
(EKR THERAPEUTICS, INC., a company incorporated in the state of Delaware whose principal) Tj
0 -12 Td
(place of business is 1545 Route 206  South, Third Floor, Bedminster, New Jersey 07921) Tj
0 -12 Td
(\("EKR"\).) Tj
0 -12 Td
() Tj
0 -12 Td
(Recitals) Tj
0 -12 Td
() Tj
0 -12 Td
(PPI owns and has all right title and interest in or has acquired exclusive rights to the) Tj
0 -12 Td
(PPI IP \(as defined below\), the Trademark \(as  defined below\) and the Product \(as defined) Tj
0 -12 Td
(below\).) Tj
0 -12 Td
() Tj
0 -12 Td
(EKR has, among other things, specialized knowledge and expertise in relation to the) Tj
0 -12 Td
(marketing and sale of pharmaceutical products.) Tj
0 -12 Td
() Tj
0 -12 Td
(Pursuant to that certain Strategic Licensing, Distribution and Marketing Agreement between) Tj
0 -12 Td
(EKR and PPI dated as of August 10, 2007  \(the "Original Agreement"\), PPI granted and EKR) Tj
0 -12 Td
(acquired the exclusive right and license to sell, offer to sell, distribute and market the) Tj
0 -12 Td
(Product in  the Territory \(as defined below\) in the Field \(as defined below\).) Tj
0 -12 Td
() Tj
0 -12 Td
(EKR and PPI desire to amend and restate the Original Agreement in its entirety as set) Tj
0 -12 Td
(forth herein in order to provide for: \(i\) certain  changes to the financial terms set) Tj
0 -12 Td
(forth in the Original Agreement, \(ii\) the transfer of Marketing Authorizations \(as defined) Tj
0 -12 Td
(below\) from PPI to      -1-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(EKR, and EKR's assumption of obligations thereunder, \(iii\) the transfer of title to) Tj
0 -12 Td
(certain manufacturing equipment from PPI to EKR and the lease  of such equipment back from) Tj
0 -12 Td
(EKR to PPI and \(iv\) certain other changes as are set forth herein; all of the foregoing) Tj
0 -12 Td
(subject to and in accordance  with the terms and conditions of this Agreement.) Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
4 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 3 0 R >>
endobj
5 0 obj
<< /Length 2764 >>
stream
BT
/F1 10 Tf
72 720 Td
(NOW THEREFORE, in consideration of the following mutual agreements and covenants set forth) Tj
0 -12 Td
(herein and intending to be legally  bound hereby, PPI and EKR \(each, a "Party"  and) Tj
0 -12 Td
(collectively, the "Parties"\)  acknowledge and agree that this Agreement shall amend and) Tj
0 -12 Td
(supersede in its entirety the Original Agreement and hereby agree as follows:) Tj
0 -12 Td
() Tj
0 -12 Td
(Operative Provisions) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-2-) Tj
0 -12 Td
() Tj
0 -12 Td
(1. Definitions   1.1 As used in this Agreement, the following words and expressions have) Tj
0 -12 Td
(the following meanings:) Tj
0 -12 Td
() Tj
0 -12 Td
("Affiliate") Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(With respect to any Party to this Agreement shall mean any company, corporation, firm,) Tj
0 -12 Td
(individual or other  entity which Controls, is Controlled by or is under common Control) Tj
0 -12 Td
(with such Party to this Agreement for only  so long as such Control exists;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-3-) Tj
0 -12 Td
() Tj
0 -12 Td
("Applicable Laws") Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Shall mean all laws, rules and regulations regarding the manufacture, packaging, labeling,) Tj
0 -12 Td
(import, export,  storage, distribution, representation, promotion, marketing and sale of) Tj
0 -12 Td
(the Products including but not limited to  the Federal Food, Drug and Cosmetic Act of) Tj
0 -12 Td
(1938, as amended \("FD&C Act"\) and the Controlled Substances  Act, as amended \(21 U.S.C.) Tj
0 -12 Td
(801 et seq.\), or as defined in attendant regulations promulgated under authorities) Tj
0 -12 Td
(granted by the FD&C Act, together with any equivalent laws, rules, regulations, codes or) Tj
0 -12 Td
(guidelines having  effect in any jurisdiction in the Territory;) Tj
0 -12 Td
() Tj
0 -12 Td
("Calendar Year"    Shall mean the period of twelve months commencing on 1st January in any) Tj
0 -12 Td
(year, and each consecutive period  of twelve months thereafter during the Term;) Tj
0 -12 Td
() Tj
0 -12 Td
("cGMP"    Means Current Good Manufacturing Practices pursuant to 21 CFR Parts 210 and 211,) Tj
0 -12 Td
(as may be amended from  time to time;) Tj
0 -12 Td
() Tj
0 -12 Td
("Commercial Launch") Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Shall mean the date of the first arm's length sale by EKR to an unaffiliated Third Party) Tj
0 -12 Td
(customer for commercial  use of Product in a country within the Territory following the) Tj
0 -12 Td
(grant of Marketing Authorization and any  necessary pricing approval in that country;) Tj
0 -12 Td
ET
endstream
endobj
6 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 5 0 R >>
endobj
7 0 obj
<< /Length 2677 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
("Commercialization  Committee"   Shall mean the committee to be set up under the terms of) Tj
0 -12 Td
(Article 5;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-4-) Tj
0 -12 Td
() Tj
0 -12 Td
("Competing Product") Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Means any [**] \([**] hours\) [**] preparation \(other than the Product\) available in a) Tj
0 -12 Td
(country in the Territory  which competes or would compete directly with the Product. For) Tj
0 -12 Td
(the avoidance of doubt, the definition of  "Competing Product" does not include) Tj
0 -12 Td
(Depobupivacaine or any improvement thereto;) Tj
0 -12 Td
() Tj
0 -12 Td
("Confidential Information") Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Means all confidential information, data and materials in whatever form disclosed by or on) Tj
0 -12 Td
(behalf of one Party  or its Affiliates to the other Party or its Affiliates including,) Tj
0 -12 Td
(without limitation, the terms of this Agreement,  data, formulae, unpublished patent) Tj
0 -12 Td
(disclosures, processes, protocols, marketing studies, sales information,  specifications) Tj
0 -12 Td
(and know-how, \(and, in the case of EKR's Confidential Information, EKR's marketing plans) Tj
0 -12 Td
(and  EKR's sales forecasts\), but excluding information which either Party can establish by) Tj
0 -12 Td
(written documentation:) Tj
0 -12 Td
() Tj
0 -12 Td
(\(i\) at the time of disclosure, is in the public domain or is public knowledge;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(ii\) after disclosure, becomes part of the public domain by publication, except by breach) Tj
0 -12 Td
(of any obligation of  confidentiality by a Party hereto or an Affiliate of such Party;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(iii\) was already in its possession at the time of its receipt and was not acquired) Tj
0 -12 Td
(directly or indirectly from the  other Party or its Affiliates; or) Tj
0 -12 Td
() Tj
0 -12 Td
(\(iv\) received from Third Parties who were lawfully entitled to disclose such information;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-5-) Tj
0 -12 Td
() Tj
0 -12 Td
("Control") Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Means in relation to any Party or an Affiliate the possession directly or indirectly, of) Tj
0 -12 Td
(the power to direct or  cause the direction of the management and policies of such firm,) Tj
0 -12 Td
(person or entity, by contract or otherwise, or  the ownership either directly or) Tj
0 -12 Td
(indirectly of 50% or more of the voting securities of such Party;) Tj
0 -12 Td
ET
endstream
endobj
8 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 7 0 R >>
endobj
9 0 obj
<< /Length 2549 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
("Copyrights") Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Means \(i\) the copyright registrations and applications for registration identified on) Tj
0 -12 Td
(Schedule III, \(ii\) works of  authorship whether or not copyrightable and \(iii\) any other) Tj
0 -12 Td
(copyrights and works, together with all common law  rights, used or held for use by PPI or) Tj
0 -12 Td
(any of its Affiliates in connection with the Products in the Territory  \(including, but) Tj
0 -12 Td
(not limited to, any license or other rights of PPI or any of its Affiliates, whether as a) Tj
0 -12 Td
(licensor,  licensee or otherwise relation to any of the foregoing\);) Tj
0 -12 Td
() Tj
0 -12 Td
("Current Base Price"    Means the Product's current \(as of the Effective Date\) net average) Tj
0 -12 Td
(selling price of $[**] \([**] mg\) and $[**]  \([**] mg\);) Tj
0 -12 Td
() Tj
0 -12 Td
("DEA"    Shall mean the United States Drug Enforcement Administration and any successor) Tj
0 -12 Td
(thereto performing similar  functions;) Tj
0 -12 Td
() Tj
0 -12 Td
("Distribution Rights"   Shall have the meaning set forth in Section 2.1 hereof;) Tj
0 -12 Td
() Tj
0 -12 Td
("Domain Name"    Shall mean Depodur.com and any other domain names owned or licensed by) Tj
0 -12 Td
(PPI related to the Product set forth  on Schedule IV hereto;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-6-) Tj
0 -12 Td
() Tj
0 -12 Td
("EKR Improvement"   Means any Improvement generated, conceived, reduced to practice or) Tj
0 -12 Td
(other created during the Term by EKR or  any of its Affiliates.) Tj
0 -12 Td
() Tj
0 -12 Td
(Endo/PPI Unit Sales   Shall have the meaning set forth in Section 3.19 hereof;) Tj
0 -12 Td
() Tj
0 -12 Td
(Endo Product   Means: \(i\) DepoDur Injectible Liposomal Epidural 10 mg/ml NDC # [**]; and) Tj
0 -12 Td
(\(ii\) DepoDur Injectible Liposomal  Epidural 15 mg/1.5 ml NDC # [**];) Tj
0 -12 Td
() Tj
0 -12 Td
("Effective Date"   Means August 10, 2007;) Tj
0 -12 Td
() Tj
0 -12 Td
("FDA"   Means the United States Food and Drug Administration or any successor thereto) Tj
0 -12 Td
(performing similar functions;) Tj
0 -12 Td
() Tj
0 -12 Td
("Field"   Means the management of post-operative pain following major orthopedic,) Tj
0 -12 Td
(abdominal or pelvic surgery;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-7-) Tj
0 -12 Td
() Tj
0 -12 Td
("Force Majeure") Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
10 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 9 0 R >>
endobj
11 0 obj
<< /Length 2723 >>
stream
BT
/F1 10 Tf
72 720 Td
(Means in relation to either Party, any cause affecting the performance of this Agreement) Tj
0 -12 Td
(or the Supply  Agreement arising from or attributable to any acts, events, non-happenings,) Tj
0 -12 Td
(omissions or accidents beyond the  reasonable control of the Party to perform and in) Tj
0 -12 Td
(particular but without limiting the generality thereof shall  include strikes and labor) Tj
0 -12 Td
(disturbances, lock-outs, industrial action, civil commotion, riot, invasion, war, threat) Tj
0 -12 Td
(of  or preparation for war, terrorist activity, fire, explosion, storm, flood, earthquake,) Tj
0 -12 Td
(subsidence, epidemic or other  natural physical disaster, impossibility of the use of) Tj
0 -12 Td
(railways, shipping, aircraft, motor transport, or other means  of public or private) Tj
0 -12 Td
(transport, failure or suspension of utilities, unavailability, shortage or interruption in) Tj
0 -12 Td
(the  supply of raw material, and political interference with the normal operation of) Tj
0 -12 Td
(either Party;) Tj
0 -12 Td
() Tj
0 -12 Td
("Improvements") Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Means any discovery, development, improvement, know-how or patent relating to the Product) Tj
0 -12 Td
(generated,  conceived, reduced to practice or otherwise created during the Term by PPI or) Tj
0 -12 Td
(EKR \(or any Affiliate of PPI or  EKR\);) Tj
0 -12 Td
() Tj
0 -12 Td
("Joint Improvements"   Means any Improvements generated, conceived, reduced to practice or) Tj
0 -12 Td
(other created jointly by EKR and PPI or  their Affiliates.) Tj
0 -12 Td
() Tj
0 -12 Td
("Known In-Channel  Product Units"   Shall have the meaning set forth in Section 3.19) Tj
0 -12 Td
(hereof;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-8-) Tj
0 -12 Td
() Tj
0 -12 Td
("Marketing Authorization") Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Means the new drug application \("NDA"\) and all other necessary regulatory and governmental) Tj
0 -12 Td
(approvals by a  Regulatory Authority or other governmental body required to market and) Tj
0 -12 Td
(sell the Product in any country of the  Territory, including, but not limited to, those) Tj
0 -12 Td
(set forth on Schedule V hereto;) Tj
0 -12 Td
() Tj
0 -12 Td
("Marketing Plan"   Means the plan for the marketing, distribution and sale of the Product) Tj
0 -12 Td
(in the Territory submitted to the  Commercialization Committee in accordance with Section) Tj
0 -12 Td
(5.4;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-9-) Tj
0 -12 Td
() Tj
0 -12 Td
("Net Sales") Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
12 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 11 0 R >>
endobj
13 0 obj
<< /Length 3074 >>
stream
BT
/F1 10 Tf
72 720 Td
(Means total gross sales of Product invoiced by EKR, its Affiliates and sub-distributors in) Tj
0 -12 Td
(arms length sales to  Third Parties, less the following amounts actually incurred,) Tj
0 -12 Td
(deducted, accrued or allowed:) Tj
0 -12 Td
() Tj
0 -12 Td
(\(i\) transport, freight and insurance costs which are separately stated;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(ii\) sales and excise taxes and duties;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(iii\) normal and customary trade, quantity and cash discounts, rebates and chargebacks;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(iv\) amounts repaid or credited for properly rejected, returned or recalled goods or) Tj
0 -12 Td
(resulting from retroactive  price adjustments related to the Product;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(v\) amounts incurred or resulting from government \(or an agency thereof\) mandated or) Tj
0 -12 Td
(managed care or other  rebate programs now existing or implemented hereafter;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(vi\) any other identifiable amounts included in gross sales of the Product that were or) Tj
0 -12 Td
(ultimately will be credited  and that are substantially similar to those listed) Tj
0 -12 Td
(hereinabove; and) Tj
0 -12 Td
() Tj
0 -12 Td
(\(vii\) any other deductions allowed by GAAP which effectively reduce the net selling price) Tj
0 -12 Td
(of Product;) Tj
0 -12 Td
() Tj
0 -12 Td
("PPI Improvement"   Means any Improvement generated, conceived, reduced to practice or) Tj
0 -12 Td
(otherwise created during the Term by  PPI or any of its Affiliates;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-10-) Tj
0 -12 Td
() Tj
0 -12 Td
("PPI IP"   Means the Copyrights, PPI Know-How, PPI Patents and PPI Improvements; and PPI's) Tj
0 -12 Td
(interest in Joint  Improvements;) Tj
0 -12 Td
() Tj
0 -12 Td
("PPI Know-How") Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Means all information, procedures, instructions, techniques, data, technical information,) Tj
0 -12 Td
(knowledge and  experience \(including, without limitation, toxicological, pharmaceutical,) Tj
0 -12 Td
(clinical, non-clinical and medical data,  health registration data and marketing data\),) Tj
0 -12 Td
(designs, dossiers \(including, without limitation, manufacturing  assay and quality control) Tj
0 -12 Td
(dossiers\) manufacturing formulae, processing specifications, sales and marketing) Tj
0 -12 Td
(materials and technology relating to the Product;) Tj
0 -12 Td
() Tj
0 -12 Td
("PPI Patents") Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Means those patents set out in Schedule I which cover the Products and such other patents) Tj
0 -12 Td
(as PPI may include  from time to time, including additions, divisions, confirmations,) Tj
0 -12 Td
(continuations-in-part, substitutions, re-issues,  re-examinations, extensions,) Tj
0 -12 Td
(registrations, patent terms extensions, supplementary protection certificates and) Tj
0 -12 Td
(renewals of any of the above or any other patents owned or licensed by PPI subsequent to) Tj
0 -12 Td
ET
endstream
endobj
14 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 13 0 R >>
endobj
15 0 obj
<< /Length 2385 >>
stream
BT
/F1 10 Tf
72 720 Td
(the Effective Date  which cover the Products or any Improvements;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-11-) Tj
0 -12 Td
() Tj
0 -12 Td
("Product\(s\)") Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Means: \(i\) DepoDur Injectible Liposomal Epidural [**] mg/ml [**]; \(ii\) DepoDur Injectible) Tj
0 -12 Td
(Liposomal Epidural  [**] mg/[**] ml [**]; \(iii\) such other presentations and dosages which) Tj
0 -12 Td
(hereafter receive Marketing  Authorization in any country of the Territory; in each case) Tj
0 -12 Td
(for epidural administration presented in Vials or  other approved vessels, appropriately) Tj
0 -12 Td
(packaged and labeled for sale to end users and \(iv\) any and all  Improvements of the items) Tj
0 -12 Td
(listed in clauses \(i\) through \(iii\).) Tj
0 -12 Td
() Tj
0 -12 Td
("Promotional Materials"   Means promotional, sales, marketing, educational and training) Tj
0 -12 Td
(materials which are necessary to support the  marketing of the Products;) Tj
0 -12 Td
() Tj
0 -12 Td
("Quarter"   Means a three month period ending on the last day of March, June, September or) Tj
0 -12 Td
(December in any Calendar  Year;) Tj
0 -12 Td
() Tj
0 -12 Td
("Regulatory Authority"   Means any competent regulatory authority or other governmental) Tj
0 -12 Td
(body \(for example, but not by way of  limitation the FDA and DEA\) responsible for granting) Tj
0 -12 Td
(a Marketing Authorization in the Territory;) Tj
0 -12 Td
() Tj
0 -12 Td
("Royalty Cap"   Shall have the meaning set forth in Section 6.4;) Tj
0 -12 Td
() Tj
0 -12 Td
("Supply Agreement") Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Means: \(i\) with respect to periods between the Effective Date and the Agreement Date, that) Tj
0 -12 Td
(certain Supply  Agreement entered into by the Parties on the Effective Date and \(ii\) with) Tj
0 -12 Td
(respect to periods on or after the  Agreement Date, that certain Amended and Restated) Tj
0 -12 Td
(Supply Agreement entered into by the Parties on the  Agreement Date \(as may be amended) Tj
0 -12 Td
(from time to time\);) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
16 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 15 0 R >>
endobj
17 0 obj
<< /Length 3052 >>
stream
BT
/F1 10 Tf
72 720 Td
(-12-) Tj
0 -12 Td
() Tj
0 -12 Td
("Term"   Means the term of this Agreement as set out in Section 15;) Tj
0 -12 Td
() Tj
0 -12 Td
("Territory"   Means each of the countries and territories listed in Schedule VII;) Tj
0 -12 Td
() Tj
0 -12 Td
("Third Party"   Means any company, corporation, firm, individual or other entity but) Tj
0 -12 Td
(excluding a Party to this Agreement or an  Affiliate;) Tj
0 -12 Td
() Tj
0 -12 Td
("Trademarks"   Means those Trademarks registered or applied for set out in Schedule II;) Tj
0 -12 Td
() Tj
0 -12 Td
("Transition Services and  Inventory Agreement"   Means that certain Transition Services) Tj
0 -12 Td
(and Inventory Agreement entered into between the Parties on the  Effective Date;) Tj
0 -12 Td
() Tj
0 -12 Td
("Vial"   Means a vial containing the Product supplied to EKR in presentations and dosages) Tj
0 -12 Td
(and other relevant terms  set out in the Supply Agreement;) Tj
0 -12 Td
() Tj
0 -12 Td
("Year"   Means the period of twelve months commencing on the first Commercial Launch of) Tj
0 -12 Td
(the Product in the Territory,  and each consecutive period of twelve months thereafter) Tj
0 -12 Td
(during the Term.  1.2 In this Agreement, unless the context requires otherwise:     \(a\)) Tj
0 -12 Td
(the headings are included for convenience only and shall not affect the construction of) Tj
0 -12 Td
(this Agreement;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(b\) references to "persons" includes individuals, bodies corporate \(wherever) Tj
0 -12 Td
(incorporated\), unincorporated associations and  partnerships;     \(c\) words denoting the) Tj
0 -12 Td
(singular shall include the plural and vice versa;     \(d\) words denoting one gender shall) Tj
0 -12 Td
(include each gender and all genders; and) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-13-) Tj
0 -12 Td
() Tj
0 -12 Td
(\(e\) any reference to an enactment or statutory provision is a reference to it as it may) Tj
0 -12 Td
(have been, or may from time to time be  amended, modified, consolidated or re-enacted.) Tj
0 -12 Td
(1.3 The Schedules comprise part of and shall be construed in accordance with the terms of) Tj
0 -12 Td
(this Agreement. In the event of any inconsistency  between the Schedules and the terms of) Tj
0 -12 Td
(this Agreement, the terms of this Agreement shall prevail.) Tj
0 -12 Td
() Tj
0 -12 Td
(2. Grant of Rights   2.1 Retention of EKR. Subject to the terms of this Agreement, PPI) Tj
0 -12 Td
(hereby appoints EKR and EKR agrees to be retained as the exclusive  distributor, and) Tj
0 -12 Td
(Authorized Distributor of Record, of the Products in the Field in the Territory during the) Tj
0 -12 Td
(Term to market, distribute,  warehouse and sell the Products. EKR shall have the right to) Tj
0 -12 Td
(appoint sub-distributors hereunder in each country of the Territory.   2.2 Grant of) Tj
0 -12 Td
ET
endstream
endobj
18 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 17 0 R >>
endobj
19 0 obj
<< /Length 4028 >>
stream
BT
/F1 10 Tf
72 720 Td
(License and Distribution Rights. PPI hereby grants EKR the exclusive right and license) Tj
0 -12 Td
(\(with the right to sublicense\) to use, market, promote, sell, distribute and warehouse the) Tj
0 -12 Td
(Products \(the "Distribution Rights"\) in the Field in the Territory during the Term, as) Tj
0 -12 Td
(well as to make or have made the Products anywhere in the world for import or sale in the) Tj
0 -12 Td
(Field in the Territory in each case, under the PPI  IP provided that PPI retains all) Tj
0 -12 Td
(rights necessary to manufacture and supply the Products to EKR in accordance with this) Tj
0 -12 Td
(Agreement and the  Supply Agreement. Such grant by PPI shall include the right of EKR to) Tj
0 -12 Td
(market the Product in the Territory during the Term as an EKR  product using in addition) Tj
0 -12 Td
(to the Trademarks, EKR's own trademarks, trade dress, trade names and other proprietary) Tj
0 -12 Td
(designations in  combination with the Trademarks.   2.3 Grant of Trademark Rights. PPI) Tj
0 -12 Td
(hereby grants to EKR a royalty free and exclusive license \(with the right to sublicense\)) Tj
0 -12 Td
(to use the  Trademarks in the Territory solely in connection with the exercise of the) Tj
0 -12 Td
(Distribution Rights in the Territory during the Term \(and thereafter  as set forth in) Tj
0 -12 Td
(Section 17.4\) and EKR shall market and sell the Products under the Trademarks. For the) Tj
0 -12 Td
(avoidance of doubt, the term  "exclusive" for the) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-14-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(purposes of Sections 2.1, 2.2 and 2.3 means to the exclusion of all others, including PPI) Tj
0 -12 Td
(and its Affiliates, except to the extent necessary to  enable PPI to perform its specific) Tj
0 -12 Td
(obligations under this Agreement and the Supply Agreement. Notwithstanding the foregoing,) Tj
0 -12 Td
(nothing  contained herein shall prohibit PPI from utilizing the Trademarks in the) Tj
0 -12 Td
(Territory in connection with its business for the sole purpose of signifying that PPI is) Tj
0 -12 Td
(the manufacturer of the Products for EKR.   2.4 Transfer of Domain Names. On the Effective) Tj
0 -12 Td
(Date, PPI has transferred the Domain Names to EKR for use in connection with the exercise) Tj
0 -12 Td
(of  the Distribution Rights. PPI has provided EKR with reasonable assistance as was) Tj
0 -12 Td
(necessary to effectuate the transfer of the Domain  Names. Upon any termination or) Tj
0 -12 Td
(expiration of this Agreement, EKR shall promptly transfer the Domain Names back to PPI.) Tj
0 -12 Td
(2.5 Condition of Appointment. The acceptance of forecasts and orders for the Products \(as) Tj
0 -12 Td
(provided in the Supply Agreement\), and PPI's obligation to supply the Product to EKR shall) Tj
0 -12 Td
(at all times be conditioned by the Marketing Authorization for the Product being in force) Tj
0 -12 Td
(in  the country of Territory to which such acceptance and order relates.) Tj
0 -12 Td
() Tj
0 -12 Td
(3. Undertakings of PPI   3.1 Manufacturing Activities. Subject to Section 17.5, PPI shall) Tj
0 -12 Td
(manufacture and supply, or procure the manufacture and supply of, the Product  in) Tj
0 -12 Td
(accordance with the terms and conditions of the Supply Agreement.   3.2 Transfer of) Tj
0 -12 Td
(Transferred NDA. Effective as of the Agreement Date, PPI hereby sells, transfers, conveys) Tj
0 -12 Td
(and assigns to EKR all right, title  and interest in and to [**] \(the "Transferred NDA"\).) Tj
0 -12 Td
(Each Party shall, within five \(5\) business days after the Agreement Date, file with the) Tj
0 -12 Td
(FDA a notice letter, substantially in the form attached as Schedule XI\(A\) or Schedule) Tj
0 -12 Td
(XI\(B\) \(as applicable\), regarding the transfer to EKR of  the Transferred NDA. PPI) Tj
0 -12 Td
ET
endstream
endobj
20 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 19 0 R >>
endobj
21 0 obj
<< /Length 3920 >>
stream
BT
/F1 10 Tf
72 720 Td
(represents, warrants and covenants that: \(i\) prior to the Agreement Date, it has provided) Tj
0 -12 Td
(EKR with complete, up- to-date copies of the Transferred NDA and all material) Tj
0 -12 Td
(correspondence with Regulatory Authorities in the) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-15-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Territory in connection with the Transferred NDA \(including, but not limited to, any) Tj
0 -12 Td
(periodic and annual report submissions, and all  adverse event reports and data\) and \(ii\)) Tj
0 -12 Td
(on the Agreement Date, EKR shall receive sole ownership of, and good and valid title to,) Tj
0 -12 Td
(the  Transferred NDA, free and clear of any liens and encumbrances. For the avoidance of) Tj
0 -12 Td
(doubt, nothing in this Agreement regarding the  appointment of EKR as PPI's distributor of) Tj
0 -12 Td
(the Products shall be construed to diminish any rights of EKR as holder of the Transferred) Tj
0 -12 Td
(NDA. Upon termination of this Agreement for any reason except by EKR pursuant to Section) Tj
0 -12 Td
(16.1\(a\), EKR shall promptly transfer the Transferred NDA and related regulatory) Tj
0 -12 Td
(documentation to PPI in accordance with Section 17.1\(e\).   3.3 Maintenance of Transferred) Tj
0 -12 Td
(NDA. The Parties acknowledge that prior to the Agreement Date, PPI was responsible at its) Tj
0 -12 Td
(own cost and  expense for maintaining and updating the Transferred NDA, and agree that PPI) Tj
0 -12 Td
(shall retain all liabilities with respect to the foregoing  obligations to the extent) Tj
0 -12 Td
(relating to periods prior to the Agreement Date. Commencing as of the Agreement Date, EKR) Tj
0 -12 Td
(shall, at its own cost  and expense, maintain and update the Transferred NDA and be) Tj
0 -12 Td
(responsible for all liabilities with respect to the foregoing obligations to the  extent) Tj
0 -12 Td
(relating to periods after the Agreement Date.) Tj
0 -12 Td
() Tj
0 -12 Td
(3.4 Assistance. PPI shall, at EKR's cost and expense, provide EKR with all assistance,) Tj
0 -12 Td
(information and guidance, including where appropriate direct access to employees of and) Tj
0 -12 Td
(consultants to PPI and its Affiliates and shall use reasonable efforts to obtain such) Tj
0 -12 Td
(assistance and  access from any sub-contractors of PPI and its Affiliates \(including for) Tj
0 -12 Td
(the avoidance of doubt any manufacturers of the Product\) which is  reasonably necessary in) Tj
0 -12 Td
(relation to the conduct of any post-marketing or Phase IV studies to be conducted by EKR) Tj
0 -12 Td
(in the Territory or  otherwise in connection with the discharge of EKR's obligations under) Tj
0 -12 Td
(the terms of this Agreement \(including, but not limited to, the  maintenance of the) Tj
0 -12 Td
(Transferred NDA\); provided, however, that any such post-marketing or Phase IV studies to) Tj
0 -12 Td
(be conducted by EKR shall  be at EKR's sole cost and expense. Any labor) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(costs of PPI employees related to this assistance shall be reimbursed by EKR at a rate of) Tj
0 -12 Td
([**] dollars \($[**]\) per hour. PPI represents and  warrants that as of the Agreement Date,) Tj
0 -12 Td
(except for the studies set forth on Schedule X attached hereto \(the "Required Studies"\),) Tj
0 -12 Td
(no post- marketing or Phase IV studies are required by any applicable Regulatory Authority) Tj
0 -12 Td
(to be conducted with respect to the Product. EKR shall  be responsible for the conduct of) Tj
0 -12 Td
(the Required Studies after the Agreement Date, at its own expense, in accordance with the) Tj
0 -12 Td
(requirements  of the applicable Regulatory Authorities. PPI shall be responsible for all) Tj
0 -12 Td
ET
endstream
endobj
22 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 21 0 R >>
endobj
23 0 obj
<< /Length 3230 >>
stream
BT
/F1 10 Tf
72 720 Td
(costs and liabilities incurred prior to the Agreement Date with  respect to the Required) Tj
0 -12 Td
(Studies, and shall indemnify and hold harmless EKR from such costs and liabilities.) Tj
0 -12 Td
(Promptly after the Agreement  Date, PPI shall provide EKR with copies of all agreements) Tj
0 -12 Td
(relating to the Required Studies and shall assign such agreements to EKR if and  to the) Tj
0 -12 Td
(extent \(i\) such agreements are assignable in accordance with their terms and \(ii\)) Tj
0 -12 Td
(requested by EKR.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-16-) Tj
0 -12 Td
() Tj
0 -12 Td
(3.5 Adverse Events. PPI shall at its own cost and expense promptly provide EKR with all) Tj
0 -12 Td
(information in its possession or otherwise coming to  its attention relating to the) Tj
0 -12 Td
(occurrence of a serious adverse event or an adverse event \(in any jurisdiction throughout) Tj
0 -12 Td
(the world\) in  connection with the Product. PPI shall be responsible, to the extent) Tj
0 -12 Td
(required by Applicable Laws, to report all charges, complaints or claims  reportable to) Tj
0 -12 Td
(the FDA relating to the Product, to the extent such charges, complaints or claims are made) Tj
0 -12 Td
(prior to the Agreement Date. EKR  shall be responsible, to the extent required by) Tj
0 -12 Td
(Applicable Laws, to report all charges, complaints or claims reportable to the FDA) Tj
0 -12 Td
(relating to  the Product, to the extent such charges, complaints or claims are made after) Tj
0 -12 Td
(the Agreement Date.   3.6 Reserved.   3.7 Delivery of Materials. The Parties acknowledge) Tj
0 -12 Td
(that prior to the Agreement Date, PPI has delivered to EKR \(i\) all existing PPI produced) Tj
0 -12 Td
(Promotional Materials \(if any\) and \(ii\) any existing market research in its possession) Tj
0 -12 Td
(related to the Product.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-17-) Tj
0 -12 Td
() Tj
0 -12 Td
(3.8 Customer Orders. PPI shall at its own cost and expense during the Term, promptly) Tj
0 -12 Td
(forward to EKR any customer orders or inquiries for the Product within the Territory) Tj
0 -12 Td
(received after the Effective Date and shall inform any customers ordering the Product that) Tj
0 -12 Td
(EKR is now  distributing the Product and provide such customers with EKR's address and) Tj
0 -12 Td
(telephone number.   3.9 Payment of Third Party Royalties. During the Term, PPI shall be) Tj
0 -12 Td
(solely responsible for and pay any royalties or other amounts due to Third Parties related) Tj
0 -12 Td
(to the Product and shall indemnify and hold EKR harmless from any claims arising from or) Tj
0 -12 Td
(related thereto.   3.10 Customer Returns. PPI shall at its own cost and expense be) Tj
0 -12 Td
(responsible for all customer returns of Product sold prior to the Effective Date.   3.11) Tj
0 -12 Td
(Governmental Rebates. PPI shall at its own cost and expense be responsible for all) Tj
0 -12 Td
ET
endstream
endobj
24 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 23 0 R >>
endobj
25 0 obj
<< /Length 4102 >>
stream
BT
/F1 10 Tf
72 720 Td
(discounts, rebates, or promotional allowances/incentive programs deemed to be "discount[s]) Tj
0 -12 Td
(or other reduction[s] in price" for purposes of 42 U.S.C. Section 1320a-7b\(b\)\(3\)\(A\) and) Tj
0 -12 Td
(may be subject  to the reporting requirements under state and federal Medicaid and) Tj
0 -12 Td
(Medicare laws for sales of Product prior to the Effective Date. PPI  represents that it is) Tj
0 -12 Td
(aware of its obligations to report discounts resulting from this Agreement to the) Tj
0 -12 Td
(appropriate reimbursing agencies and  authorities \(including Medicaid and Medicare\). PPI) Tj
0 -12 Td
(is responsible for complying with and agrees to comply with all applicable requirements,) Tj
0 -12 Td
(if any, in respect of providing information on such discounts to reimbursing agencies) Tj
0 -12 Td
(\(including Medicaid and Medicare\) and other entities  in accordance with Applicable Laws) Tj
0 -12 Td
(and regulations for sales of Product prior to the Effective Date and for sales of any PPI) Tj
0 -12 Td
(labeled product  subsequent the Effective Date.   3.12 Chargebacks. PPI shall at its own) Tj
0 -12 Td
(cost and expense be responsible for all chargebacks for sales of Product prior to the) Tj
0 -12 Td
(Effective Date.   3.13 Exclusivity. During the Term, PPI and its Affiliates shall not: \(i\)) Tj
0 -12 Td
(file for Marketing Authorization with respect to any Competing Product in  any country in) Tj
0 -12 Td
(the Territory, \(ii\) manufacture or have manufactured any Competing Product in any country) Tj
0 -12 Td
(in the Territory, \(iii\) market or  have marketed any Competing Product in any country in) Tj
0 -12 Td
(the Territory or \(iv\) license any Third Party to do any of the foregoing.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(EKR - Graham May, MD - CMO   PPI - Gary Patou, MD - CMO) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-18-) Tj
0 -12 Td
() Tj
0 -12 Td
(3.14 Product Development. PPI shall at its own cost and expense cooperate fully and assist) Tj
0 -12 Td
(EKR with the preparation of any necessary  submissions to any of the Regulatory) Tj
0 -12 Td
(Authorities in the Territory for the development and approval or supplemental approval\(s\)) Tj
0 -12 Td
(of the  Products, including, but not limited to, by providing access to all PPI Know-How,) Tj
0 -12 Td
(the drug master file and any other information necessary  for approval or supplemental) Tj
0 -12 Td
(approval of the Product in any country of the Territory. In addition, PPI shall cooperate) Tj
0 -12 Td
(fully in participating  in interactions with the appropriate Regulatory Authorities) Tj
0 -12 Td
(including FDA related to such product development so as to enable EKR to  fully exploit) Tj
0 -12 Td
(the Distribution Rights granted hereunder. For purpose of this Section, the contact person) Tj
0 -12 Td
(for each of the parties is set forth  below.) Tj
0 -12 Td
() Tj
0 -12 Td
(3.15 Reserved.   3.16 Recalls and PostMarket Notifications. All costs of safety alerts and) Tj
0 -12 Td
(all other forms of notifications regarding safety risks associated with the Products in) Tj
0 -12 Td
(the United States shall be borne by PPI to the extent arising prior to the Agreement Date) Tj
0 -12 Td
(and by EKR to the extent arising  after the Agreement Date.   3.17 Compliance. During the) Tj
0 -12 Td
(Term PPI shall at its own cost and expense take all actions necessary to comply with all) Tj
0 -12 Td
(Applicable Laws and  obtain and maintain all necessary license, permits, records and) Tj
0 -12 Td
(authorizations PPI is required to obtain and maintain hereunder so as to  enable PPI to) Tj
0 -12 Td
(perform its obligations hereunder and under the Supply Agreement so as to enable EKR to) Tj
0 -12 Td
(fully exercise the Distribution  Rights.   3.18 Assignment of ICS Agreement. The Parties) Tj
0 -12 Td
(acknowledge that effective upon the termination or expiration of the Transition Services) Tj
0 -12 Td
ET
endstream
endobj
26 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 25 0 R >>
endobj
27 0 obj
<< /Length 2985 >>
stream
BT
/F1 10 Tf
72 720 Td
(and Inventory Agreement, PPI has) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-19-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(assigned to EKR all of PPI's right, title and interest under that certain Commercial) Tj
0 -12 Td
(Outsourcing Services Agreement between PPI \(f/k/a  SkyePharma, Inc.\) and Integrated) Tj
0 -12 Td
(Commercialization Solutions, Inc. \("ICS"\)  dated April 3, 2007 \(the "ICS Agreement"\), and) Tj
0 -12 Td
(EKR has  assumed all obligations and liabilities under the ICS Agreement arising after the) Tj
0 -12 Td
(Effective Date. The Parties further acknowledge that as of  the Effective Date, the) Tj
0 -12 Td
(Parties have entered into an Assignment and Assumption Agreement to further evidence the) Tj
0 -12 Td
(foregoing assignment  and assumption of the ICS Agreement.   3.19 Product in Channel. All) Tj
0 -12 Td
(sales of Product conducted by PPI and its distributors and wholesalers \(and, to the) Tj
0 -12 Td
(knowledge of PPI, by Endo Pharmaceuticals and its distributors and wholesalers\) during the) Tj
0 -12 Td
(six month period prior to the Effective Date have been conducted in the  ordinary course) Tj
0 -12 Td
(upon standard payment terms. PPI has provided EKR: \(i\) all information regarding sales by) Tj
0 -12 Td
(Endo Pharmaceuticals during  the six month period prior to the Effective Date and \(ii\) all) Tj
0 -12 Td
(information regarding the number of units of Product and Endo Product that were  in the) Tj
0 -12 Td
(possession or control of PPI or Endo Pharmaceuticals \(and their respective distributors or) Tj
0 -12 Td
(wholesalers\) as of the Effective Date \(the  "Known In-Channel Product Units"\). Within 10) Tj
0 -12 Td
(days of the end of each month following the Effective Date, PPI shall provide EKR with) Tj
0 -12 Td
(copies of: \(i\) any reports provided by Endo Pharmaceuticals of the number of units of Endo) Tj
0 -12 Td
(Product sold to hospitals or other customers  during the preceding month by Endo, and \(ii\)) Tj
0 -12 Td
(information possessed by PPI of such sales by PPI or any of their respective distributors) Tj
0 -12 Td
(or  wholesalers \(the "Endo/PPI Unit Sales"\).   3.20 Sale and Leaseback of Transferred) Tj
0 -12 Td
(Equipment.) Tj
0 -12 Td
() Tj
0 -12 Td
(\(a\) In consideration of and subject to EKR's payment of the Equipment Purchase Price \(as) Tj
0 -12 Td
(defined below\), effective as of the  Agreement Date, PPI hereby sells, transfers, conveys) Tj
0 -12 Td
(and assigns to EKR all right, title and interest in and to the equipment  described on) Tj
0 -12 Td
(Schedule XII \(the "Transferred Equipment"\). The) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
28 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 27 0 R >>
endobj
29 0 obj
<< /Length 3442 >>
stream
BT
/F1 10 Tf
72 720 Td
(-20-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Parties shall share equally the responsibility for any and all sales, transfer and) Tj
0 -12 Td
(conveyance taxes occasioned by the sale of the  Transferred Equipment by PPI to EKR. PPI) Tj
0 -12 Td
(represents and warrants that: \(i\) on the Agreement Date, EKR shall receive sole  ownership) Tj
0 -12 Td
(of, and good and valid title to, the Transferred Equipment, free and clear of any liens) Tj
0 -12 Td
(and encumbrances, \(ii\) the  Transferred Equipment as of the Agreement Date is in good) Tj
0 -12 Td
(operating condition, normal wear and tear excepted and \(iii\) the  Transferred Equipment) Tj
0 -12 Td
(constitutes all specialized equipment that is used in the manufacture of Product by PPI as) Tj
0 -12 Td
(of the Agreement  Date. For purposes of clarity, the Transferred Equipment does not) Tj
0 -12 Td
(include any standard, non-specialized equipment generally found  in manufacturing) Tj
0 -12 Td
(facilities or available to manufacturers of products similar to the Product \(e.g.,) Tj
0 -12 Td
(refrigerators, freezers, safes,  incubators, stability chambers, clean utilities,) Tj
0 -12 Td
(supportive utilities, temperature control units and other supportive equipment\). On the) Tj
0 -12 Td
(Agreement Date, PPI shall execute and deliver to EKR a Bill of Sale with respect to the) Tj
0 -12 Td
(Transferred Equipment substantially in the  form attached hereto as Exhibit 3.20\(a\).) Tj
0 -12 Td
(\(b\) EKR will pay PPI [**] Dollars \($[**]\) for the Transferred Equipment \(the "Equipment) Tj
0 -12 Td
(Purchase Price"\) as follows:) Tj
0 -12 Td
() Tj
0 -12 Td
(\(i\) within five \(5\) days after the Agreement Date, EKR will pay PPI [**] Dollars \($[**]\)) Tj
0 -12 Td
(of the Equipment Purchase Price in  cash; and) Tj
0 -12 Td
() Tj
0 -12 Td
(\(ii\) concurrently with the execution of this Agreement, EKR will issue to PPI a promissory) Tj
0 -12 Td
(note in principal amount of [**]  Dollars \($[**]\), such note to be substantially in the) Tj
0 -12 Td
(form attached hereto as Exhibit 3.20\(b\) \(the "Promissory Note"\).) Tj
0 -12 Td
() Tj
0 -12 Td
(\(c\) Commencing as of the Agreement Date, EKR agrees to lease the Transferred Equipment to) Tj
0 -12 Td
(PPI through the end of the then-current  calendar quarter and, subject to renewal as) Tj
0 -12 Td
(provided below, on a calendar quarter-to-calendar quarter) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-21-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(basis thereafter \(the "Lease Term"\), for use solely in connection with the \(i\) performance) Tj
0 -12 Td
(of PPI's obligations under the Supply  Agreement, \(ii\) the supply of Products to PPI's) Tj
0 -12 Td
(other licensees and collaborators and \(iii\) the supply of placebo for PPI's Exparel) Tj
0 -12 Td
(product to PPI's other licensees and collaborators. The Lease Term shall automatically) Tj
0 -12 Td
(renew at the end of each calendar quarter of  the Lease Term. The Lease Term will) Tj
0 -12 Td
(automatically terminate immediately upon \(i\) any termination or expiration of this) Tj
0 -12 Td
(Agreement  and/or the Supply Agreement or \(ii\) any exercise by EKR of the Step-in Right) Tj
0 -12 Td
(described in Section 17.5 below.) Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
30 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 29 0 R >>
endobj
31 0 obj
<< /Length 3223 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(d\) At any time between the Agreement Date and July 1, 2015, EKR shall have the right,) Tj
0 -12 Td
(exercisable upon sixty \(60\) days prior written  notice to PPI, to terminate the Lease Term) Tj
0 -12 Td
(and sell the Transferred Equipment back to PPI, subject to payment by PPI to EKR within) Tj
0 -12 Td
(five \(5\) days of such notice of $[**] in cash, which if exercised shall result in \(i\) an) Tj
0 -12 Td
(offset against the unpaid balance of principal and  interest under the Promissory Note) Tj
0 -12 Td
(pursuant to Section 3.20\(f\) below; and \(ii\) the termination of the Step-in Right described) Tj
0 -12 Td
(in  Section 17.5.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(e\) At any time after July 1, 2015, PPI shall have the right, exercisable upon sixty \(60\)) Tj
0 -12 Td
(days prior written notice to EKR, to terminate the Lease Term and repurchase the) Tj
0 -12 Td
(Transferred Equipment from EKR, subject to payment by PPI to EKR within five \(5\) days of) Tj
0 -12 Td
(such  notice of any principal paid by EKR under the Promissory Note, which if exercised) Tj
0 -12 Td
(shall result in the termination of the Step-in Right  set forth in Section 17.5.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(f\) If, upon the expiration or earlier termination of the Lease Term \(except as provided) Tj
0 -12 Td
(in Section 3.20\(e\) above\), the aggregate amount  of repayments and Royalty Offsets \(as) Tj
0 -12 Td
(defined below\) earned by EKR pursuant to Section 6.3 below have not equaled or exceeded) Tj
0 -12 Td
(the Advanced Royalty Payment \(as defined below\), then EKR shall have the right, at its) Tj
0 -12 Td
(option, to offset against the unpaid balance  of principal and interest under the) Tj
0 -12 Td
(Promissory Note, by an amount equal to the) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-22-) Tj
0 -12 Td
() Tj
0 -12 Td
(then-current balance of the Advanced Royalty Payment that has not yet been recouped by EKR) Tj
0 -12 Td
(through repayments and Royalty  Offsets pursuant to Section 6.3 below \(the "Remaining) Tj
0 -12 Td
(Balance"\), in which event PPI's obligations under Section 6.3 below with  respect to) Tj
0 -12 Td
(repayment of the Advanced Royalty Payment shall be deemed to have been paid in full.) Tj
0 -12 Td
() Tj
0 -12 Td
(\(g\) In consideration of the foregoing lease, PPI shall pay EKR [**] lease payments in the) Tj
0 -12 Td
(amount of $[**]per calendar quarter, with the  first lease payment due on the Agreement) Tj
0 -12 Td
(Date and each subsequent lease payment due during the Lease Term on the first day of  each) Tj
0 -12 Td
(calendar quarter thereafter.) Tj
0 -12 Td
() Tj
0 -12 Td
(\(h\) PPI shall not, without the prior, written consent of EKR, remove any of the) Tj
0 -12 Td
(Transferred Equipment from the locations within the  Approved Facilities \(as defined in) Tj
0 -12 Td
(the Supply Agreement\) where such Transferred Equipment is installed as of the Agreement) Tj
0 -12 Td
(Date.) Tj
0 -12 Td
ET
endstream
endobj
32 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 31 0 R >>
endobj
33 0 obj
<< /Length 3427 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(i\) During the Lease Term, PPI shall: \(i\) assume the risk of loss or damage to the) Tj
0 -12 Td
(Transferred Equipment; \(ii\) maintain the Transferred Equipment in good operating condition) Tj
0 -12 Td
(and appearance, ordinary wear and tear excepted; \(iii\) comply with all requirements) Tj
0 -12 Td
(necessary to enforce any warranty rights and to maintain eligibility for any manufacturer) Tj
0 -12 Td
(maintenance program; \(iv\) promptly repair  any repairable damage to the Transferred) Tj
0 -12 Td
(Equipment and \(v\) maintain property damage and liability insurance and insurance against) Tj
0 -12 Td
(loss or damage to the Transferred Equipment as part of PPI's general liability insurance.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(j\) If any of the Transferred Equipment is lost, stolen, destroyed, damaged beyond repair) Tj
0 -12 Td
(or in the event of any condemnation,  confiscation, seizure or expropriation of any) Tj
0 -12 Td
(Transferred Equipment \("Casualty Transferred Equipment"\), PPI shall promptly \(i\)  notify) Tj
0 -12 Td
(EKR of the same, and \(ii\) pay to EKR an amount equal to the estimated in-place, fair) Tj
0 -12 Td
(market value of the Casualty Transferred  Equipment as of the date of the loss, as) Tj
0 -12 Td
(determined by a mutually agreed nationally recognized) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-23-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(appraiser; provided that \(i\) in the event there are any amounts owed to PPI under the) Tj
0 -12 Td
(Promissory Note as of the date of such loss,  PPI shall have the right, at its option, to) Tj
0 -12 Td
(offset against the unpaid balance of principal and interest under the Promissory Note, the) Tj
0 -12 Td
(amounts owed to EKR pursuant to this Section 3.20\(k\), and \(ii\) in no event shall PPI be) Tj
0 -12 Td
(required to pay EKR an amount that exceeds  [**] Dollars \($[**]\) plus the amounts paid by) Tj
0 -12 Td
(EKR pursuant to the Promissory Note.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(k\) Subject to Sections 3.20\(d\) and \(e\) and Section 6.3\(d\) and PPI's right to repurchase) Tj
0 -12 Td
(the Transferred Equipment thereunder, upon the  expiration or earlier termination of the) Tj
0 -12 Td
(Lease Term, EKR shall remove the Transferred Equipment from PPI's premises \(unless EKR at) Tj
0 -12 Td
(its option elects to retain the Transferred Equipment at PPI's premises in connection with) Tj
0 -12 Td
(EKR's exercise of step-in rights under  Section 17.5\). PPI agrees to cooperate with EKR in) Tj
0 -12 Td
(the removal of the Transferred Equipment, including providing the necessary  access to the) Tj
0 -12 Td
(Transferred Equipment and the facilities where it is located at times mutually agreed by) Tj
0 -12 Td
(the Parties, such agreement  not to be unreasonably withheld or delayed by either Party.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(l\) Upon termination of the Lease Term, unless PPI has repurchased the Transferred) Tj
0 -12 Td
(Equipment, EKR will, at PPI's request, use  commercially reasonable efforts to \(i\) supply) Tj
0 -12 Td
(the Product and \(ii\) supply placebo for [**], to PPI's other licensees and collaborators) Tj
0 -12 Td
ET
endstream
endobj
34 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 33 0 R >>
endobj
35 0 obj
<< /Length 3539 >>
stream
BT
/F1 10 Tf
72 720 Td
(outside the Territory, excluding PPI and any of its Affiliates \(the "Other PPI) Tj
0 -12 Td
(Customers"\), in each case in accordance with the  commercially reasonable requirements of) Tj
0 -12 Td
(any existing agreements between PPI and such Other PPI Customers, subject to EKR's) Tj
0 -12 Td
(receipt of payment required under such agreements for supplying such Products and/or other) Tj
0 -12 Td
(products. PPI will use commercially  reasonable efforts to cooperate with EKR so as to) Tj
0 -12 Td
(enable EKR to supply Product and, if applicable, other products, to such Other  PPI) Tj
0 -12 Td
(Customers.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-24-) Tj
0 -12 Td
() Tj
0 -12 Td
(4. Undertakings of EKR.   4.1 Marketing Authorizations. EKR shall, as determined in its) Tj
0 -12 Td
(sole discretion to be commercially reasonable, prepare studies of the markets and sales) Tj
0 -12 Td
(potential of the Products for countries in the Territory other than the United States and) Tj
0 -12 Td
(present such studies to the Committee. EKR  shall at its own cost and expense use) Tj
0 -12 Td
(commercially reasonable efforts to take those steps reasonably necessary in order to) Tj
0 -12 Td
(obtain and  thereafter maintain Marketing Authorizations \(including pricing and) Tj
0 -12 Td
(reimbursement approvals\) for the Product in those countries of the  Territory other than) Tj
0 -12 Td
(the United States which the Committee determines to present commercially viable) Tj
0 -12 Td
(opportunities for the Product. EKR  shall provide PPI with a copy of any original) Tj
0 -12 Td
(certificates of approval/registration in each country in the Territory other than the) Tj
0 -12 Td
(United  States. EKR shall provide PPI with a copy of any other registration matters) Tj
0 -12 Td
(received from the appropriate Regulatory Authorities  concerning maintenance, renewal or) Tj
0 -12 Td
(variations to the original certificates of approval/registration in each country in the) Tj
0 -12 Td
(Territory. Except as  provided in Section 3.17, EKR shall be solely responsible for, and) Tj
0 -12 Td
(shall bear all costs associated with, all regulatory activities related to the) Tj
0 -12 Td
(development and approval of the Product in the countries of the Territory \(including,) Tj
0 -12 Td
(after the Agreement Date, the United States\) and shall  own the Marketing Authorizations) Tj
0 -12 Td
(for the Product in each other country of the Territory. EKR will comply with all) Tj
0 -12 Td
(conditions and  requirements attaching to such Marketing Authorizations.   4.2 Liaison) Tj
0 -12 Td
(with Regulatory Authorities. Pursuant to Section 4.1 above, EKR shall at its own cost and) Tj
0 -12 Td
(expense liaise with the relevant  Regulatory Authorities in respect of each Marketing) Tj
0 -12 Td
(Authorization and notify PPI of all material communications relating thereto. The cost  of) Tj
0 -12 Td
(submitting any data generated by any Phase IV studies conducted by EKR which is required) Tj
0 -12 Td
(to be filed with the FDA shall be borne by  EKR and the cost of submitting any other data) Tj
0 -12 Td
(\(including data submitted to support the use of the Product for additional indications\)) Tj
0 -12 Td
(shall  also be borne by EKR;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
36 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 35 0 R >>
endobj
37 0 obj
<< /Length 3788 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-25-) Tj
0 -12 Td
() Tj
0 -12 Td
(4.3 Submission of Promotional Materials. Pursuant to Section 4.1 above, EKR shall at its) Tj
0 -12 Td
(own cost and expense submit and obtain the approvals of Regulatory Authorities in the) Tj
0 -12 Td
(Territory of Promotional Materials as required by Applicable Laws;   4.4 Pre-Launch and) Tj
0 -12 Td
(Post Launch Activities. Pursuant to Section 4.1 above, EKR shall at its own cost and) Tj
0 -12 Td
(expense carry out reasonable pre- launch market development and conduct such post-) Tj
0 -12 Td
(marketing clinical trials \(as determined solely by EKR in its reasonable business) Tj
0 -12 Td
(judgment\) in accordance with the Marketing Plan. Any data resulting from such trials shall) Tj
0 -12 Td
(be owned by EKR but shall be provided on a  royalty-free license to PPI for use outside of) Tj
0 -12 Td
(the Territory. PPI shall cooperate with EKR in connection with such pre-launch and post) Tj
0 -12 Td
(launch activities as provided in sections 3.3 and 3.14 hereof;   4.5 Launch of Products.) Tj
0 -12 Td
(Pursuant to Section 4.1 above, EKR shall at its own cost and expense launch and achieve) Tj
0 -12 Td
(Commercial Launch of the  Products in accordance with the Marketing Plan but no later than) Tj
0 -12 Td
(18 months following receipt of Marketing Authorization in each country  in the Territory) Tj
0 -12 Td
(provided however that EKR shall not be obligated to launch such Product in such country of) Tj
0 -12 Td
(the Territory where the  approved pricing in such country provides EKR a gross margin of) Tj
0 -12 Td
(less than [**]% \(after payment of Royalties, Additional Royalties and  Cost of Goods\) or) Tj
0 -12 Td
(where the launch of the Product in such country of the Territory as determined by EKR is) Tj
0 -12 Td
(not commercially reasonable.   4.6 Marketing Activities. EKR shall at its own cost and) Tj
0 -12 Td
(expense, during the term of this Agreement, promote, market, sell and distribute the) Tj
0 -12 Td
(Products to customers within the Territory and provided that PPI has supplied EKR with) Tj
0 -12 Td
(necessary quantities of Product, satisfy the  demand for the Product throughout the) Tj
0 -12 Td
(Territory. EKR shall be solely responsible for, and shall bear all costs associated with,) Tj
0 -12 Td
(all marketing  and selling activities related to the Products in the Territory;   4.7) Tj
0 -12 Td
(SubDistributors. EKR shall at its own cost and expense maintain, or use reasonable) Tj
0 -12 Td
(commercial efforts to ensure that sub-distributors maintain, adequate sales and, where) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-26-) Tj
0 -12 Td
() Tj
0 -12 Td
(appropriate, warehouse facilities and employ, or use reasonable commercial efforts to) Tj
0 -12 Td
(procure that sub-distributors employ, a sufficient  number of experienced, trained and) Tj
0 -12 Td
(qualified personnel to promote the sale of the Product in the Territory and perform, or) Tj
0 -12 Td
(procure the  performance of the activities set forth in the Marketing Plan;   4.8) Tj
0 -12 Td
(Inventory and Promotional Materials. EKR shall maintain a sufficient inventory of Product) Tj
0 -12 Td
(and support material to reasonably fulfill the requirements of its customers in the) Tj
0 -12 Td
(Territory provided that, subject to Section 17.5, PPI shall comply with the Supply) Tj
0 -12 Td
(Agreement;   4.9 Records. EKR shall maintain adequate records concerning the sale of the) Tj
0 -12 Td
(Product as required by any applicable Regulatory Authority in the Territory;   4.10) Tj
0 -12 Td
ET
endstream
endobj
38 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 37 0 R >>
endobj
39 0 obj
<< /Length 3806 >>
stream
BT
/F1 10 Tf
72 720 Td
(Promotional Materials. EKR shall provide PPI with copies of the Promotional Materials) Tj
0 -12 Td
(proposed to be used in connection with the sale of  the Products in the United States for) Tj
0 -12 Td
(approval, solely with respect to Trademark usage, \(such approval not to be unreasonably) Tj
0 -12 Td
(withheld,  conditioned or delayed\) to the extent such Promotional Materials include any) Tj
0 -12 Td
(Trademark. EKR shall submit such Promotional Materials to  PPI at least five \(5\) business) Tj
0 -12 Td
(days in advance of its intended use of the same and such Promotional Material shall be) Tj
0 -12 Td
(deemed to have  received PPI's approval unless PPI Provides EKR with written notice of) Tj
0 -12 Td
(rejection within said five \(5\) business day period and EKR shall be  authorized to) Tj
0 -12 Td
(finalize and use same. For the avoidance of doubt, any Trademark usage set forth on any) Tj
0 -12 Td
(Promotional Materials in use as of  or prior to the Agreement Date are hereby deemed to be) Tj
0 -12 Td
(approved by PPI.   4.11 Adverse Events. Each Party shall promptly provide the other Party) Tj
0 -12 Td
(with all information in its possession or otherwise coming to its  attention relating to) Tj
0 -12 Td
(the occurrence of a serious adverse event or an adverse event \(in any jurisdiction) Tj
0 -12 Td
(throughout the world\) in connection  with the Product, and promptly forward to such other) Tj
0 -12 Td
(Party information concerning any and all charges, complaints or claims reportable to  any) Tj
0 -12 Td
(Regulatory Authority relating to the Product that may come to the first Party's attention,) Tj
0 -12 Td
(and) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-27-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(otherwise comply in all respects with the adverse drug event reporting and recall) Tj
0 -12 Td
(procedures set out or referred to in the Supply Agreement  from time to time. EKR shall be) Tj
0 -12 Td
(responsible, to the extent required by Applicable Law, to report all charges, complaints) Tj
0 -12 Td
(or claims reportable  to any Regulatory Authority outside of the United States relating to) Tj
0 -12 Td
(the Product, as well as any such charges, complaints or claims  reportable to any) Tj
0 -12 Td
(Regulatory Authority inside the United States to the extent such charges, complaints or) Tj
0 -12 Td
(claims are made after the  Agreement Date.   4.12 Permits. EKR shall obtain and maintain) Tj
0 -12 Td
(all necessary licenses, permits, records and authorizations required by Applicable Laws as) Tj
0 -12 Td
(holder of the Transferred NDA after the Agreement Date and in order to exercise the) Tj
0 -12 Td
(Distribution Rights and observe and comply with all Applicable  Laws, ordinances, rules) Tj
0 -12 Td
(and regulations including, but not limited to those of the applicable Regulatory) Tj
0 -12 Td
(Authorities in the exercise of the  Distribution Rights save insofar as PPI is required to) Tj
0 -12 Td
(obtain the same as holder of the Marketing Authorizations prior to the Agreement  Date, or) Tj
0 -12 Td
(under the terms of this Agreement;   4.13 Compliance. EKR shall conduct the promotion and) Tj
0 -12 Td
(marketing and sale of the Products in accordance with Applicable Laws and with all due) Tj
0 -12 Td
(care and diligence.   4.14 Sales and Promotional Activities. In connection with the) Tj
0 -12 Td
(promotion, marketing and sale of the Product, EKR shall, without limitation:) Tj
0 -12 Td
() Tj
0 -12 Td
(\(a\) observe and comply with such storage, stock control and operational practices and) Tj
0 -12 Td
ET
endstream
endobj
40 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 39 0 R >>
endobj
41 0 obj
<< /Length 3285 >>
stream
BT
/F1 10 Tf
72 720 Td
(procedures as may be legally required  in the Territory and as reasonably specified in) Tj
0 -12 Td
(writing by PPI from time to time;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(b\) from time to time consult with PPI's representatives for the purpose of assessing the) Tj
0 -12 Td
(state of the market in each country of  the Territory and permit representatives of PPI,) Tj
0 -12 Td
(on reasonable prior notice, to inspect any premises or documents used in  connection with) Tj
0 -12 Td
(the marketing, distribution and sale of the Products;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-28-) Tj
0 -12 Td
() Tj
0 -12 Td
(\(c\) provide PPI on reasonable prior notice but not more than once in any Calendar Year,) Tj
0 -12 Td
(copies of its up-to-date price list for  the Product together with full details of) Tj
0 -12 Td
(standard discounts and any special pricing arrangements entered into or proposed  to be) Tj
0 -12 Td
(entered into;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(d\) market the Product throughout the Territory under the Trademarks and any EKR) Tj
0 -12 Td
(trademarks and ensure that all marketing  materials for the Product shall display the) Tj
0 -12 Td
(Trademarks; and) Tj
0 -12 Td
() Tj
0 -12 Td
(\(e\) comply with all applicable regulatory and statutory requirements imposed in relation) Tj
0 -12 Td
(to the Product, including, without  limitation, those imposed by the US Drug Enforcement) Tj
0 -12 Td
(Agency \("DEA"\) and other equivalent agencies in the Territory.   4.15 Prohibition on Sales) Tj
0 -12 Td
(Outside the Territory. EKR shall not directly or indirectly market distribute and/or sell) Tj
0 -12 Td
(the Product outside the Territory, or sell the product to any Third Party that EKR knows) Tj
0 -12 Td
(intends to sell or distribute the Product outside the Territory. In addition,  the Parties) Tj
0 -12 Td
(acknowledge that since the Product is a controlled substance, the DEA and other law) Tj
0 -12 Td
(enforcement agencies will not permit any  sale outside the Territory without relevant) Tj
0 -12 Td
(clearances and approvals.   4.16 Non-Compete. EKR shall not, during [**], market,) Tj
0 -12 Td
(distribute or sell a Competing Product in the Territory unless during such time an A/B) Tj
0 -12 Td
(rated generic product of the Product\(s\) is launched in such country of the Territory or in) Tj
0 -12 Td
(the event this Agreement is terminated or EKR  exercises its rights under Section 17.4) Tj
0 -12 Td
(hereof.   4.17 PPI as Exclusive Provider. During the Term, except if PPI is unable to) Tj
0 -12 Td
(supply Products \(including, but not limited to, in connection with EKR's exercise of its) Tj
0 -12 Td
(rights under Section 17.5 below\) or as provided in the Supply Agreement, EKR shall) Tj
0 -12 Td
(purchase all of its requirements  for the Product from PPI.   4.18 Packaging. During the) Tj
0 -12 Td
(Term, EKR shall not use in relation to the Product any packaging, labeling and Product) Tj
0 -12 Td
(inserts, nor any advertising literature that has not been) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
42 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 41 0 R >>
endobj
43 0 obj
<< /Length 2973 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-29-) Tj
0 -12 Td
() Tj
0 -12 Td
(approved by PPI in writing with respect to Trademark usage \(such approval not to be) Tj
0 -12 Td
(unreasonably withheld, conditioned or delayed\) or  deemed approved pursuant to Section) Tj
0 -12 Td
(4.10, to the extent such materials include any Trademark. EKR shall be responsible for) Tj
0 -12 Td
(insuring that  any packaging, labeling and Product inserts, and advertising literature) Tj
0 -12 Td
(complies with Applicable Laws.   4.19 Customer Orders. If EKR receives a request from a) Tj
0 -12 Td
(customer located outside the Territory for supply of the Product outside of the Territory,) Tj
0 -12 Td
(EKR shall promptly forward such request to PPI.   4.20 Governmental Rebates. Any) Tj
0 -12 Td
(discounts, rebates, or promotional allowances/incentive programs provided are "discount[s]) Tj
0 -12 Td
(or other reduction[s] in price" for purposes of 42 U.S.C. Section 1320a-7b\(b\)\(3\)\(A\) and) Tj
0 -12 Td
(may be subject to the reporting requirements under state and  federal Medicaid and) Tj
0 -12 Td
(Medicare laws. EKR represents that it is aware of its obligations to report discounts) Tj
0 -12 Td
(resulting from this Agreement to  the appropriate reimbursing agencies and authorities) Tj
0 -12 Td
(\(including Medicaid and Medicare\). EKR is responsible for complying with and agrees  to) Tj
0 -12 Td
(comply with all applicable requirements, if any, in respect of providing information on) Tj
0 -12 Td
(such discounts to reimbursing agencies \(including  Medicaid and Medicare\) and other) Tj
0 -12 Td
(entities in accordance with Applicable Laws and regulations.   4.21 Resale Pricing. In) Tj
0 -12 Td
(exercising the Distribution Rights, EKR shall determine resale pricing of the Products in) Tj
0 -12 Td
(its sole discretion.) Tj
0 -12 Td
() Tj
0 -12 Td
(5. Commercialization Committee.   5.1 Establishment of Committee. The Parties have) Tj
0 -12 Td
(established a Commercialization Committee \("Committee"\)  consisting of 4 individuals) Tj
0 -12 Td
(\("Committee Members"\); 2 of whom were nominated by PPI; and 2 of whom were nominated by) Tj
0 -12 Td
(EKR. The Committee Members may be  replaced by notice to the other Party and shall be) Tj
0 -12 Td
(appropriately qualified and experienced in order to make a meaningful contribution to) Tj
0 -12 Td
(Committee meetings.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-30-) Tj
0 -12 Td
() Tj
0 -12 Td
(5.2 Purpose. The purpose of the Committee is to provide a forum for the Parties to share) Tj
0 -12 Td
(information and knowledge on the on-going Commercialization of the Product including, but) Tj
0 -12 Td
ET
endstream
endobj
44 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 43 0 R >>
endobj
45 0 obj
<< /Length 3966 >>
stream
BT
/F1 10 Tf
72 720 Td
(not limited to, monitoring progress on clinical studies, reviewing clinical trial) Tj
0 -12 Td
(programs,  discussing the appropriate regulatory strategy for the Products in the) Tj
0 -12 Td
(Territory, considering proposed marketing and promotional plans,  reviewing competitor) Tj
0 -12 Td
(activity and discussing any regulatory, technical, quality assurance or safety issues in) Tj
0 -12 Td
(relation to the Product. The  Committee shall conduct its discussions in good faith with a) Tj
0 -12 Td
(view to operating to the mutual benefit of the Parties and in furtherance of the) Tj
0 -12 Td
(successful development and marketing of the Products.   5.3 Meetings. The Committee shall) Tj
0 -12 Td
(meet as often as the Committee Members may determine, but in any event not less than 2) Tj
0 -12 Td
(times per Calendar  Year. The Committee may invite individuals with special skills to) Tj
0 -12 Td
(attend such meetings where considered to be relevant and appropriate.  The quorum for) Tj
0 -12 Td
(Committee meetings shall be 2 Committee Members, comprising 1 Committee Member from each) Tj
0 -12 Td
(Party.   5.4 Marketing Plan. The Parties acknowledge that EKR has provided the Committee) Tj
0 -12 Td
(with its Marketing Plans for Calendar Years 2008 and 2009 pursuant to the Original) Tj
0 -12 Td
(Agreement. EKR shall on or before October 15  2009 and October 15  of each Calendar Year) Tj
0 -12 Td
(thereafter provide the  Committee with its Marketing Plan for the coming Calendar Year.) Tj
0 -12 Td
(Each Marketing Plan shall include, without limitation, Net Sales targets  and projections) Tj
0 -12 Td
(with respect to sales force staffing levels, market research, physician education,) Tj
0 -12 Td
(marketing expenditure, post-approval  clinical trials and advertising. With regard to pre-) Tj
0 -12 Td
(marketing clinical trials, the design and conduct shall be subject to the written approval) Tj
0 -12 Td
(of  PPI, such approval not to be unreasonably withheld or delayed.   5.5 Decision Making.) Tj
0 -12 Td
(Decisions of the Committee shall be made as follows:) Tj
0 -12 Td
() Tj
0 -12 Td
(\(a\) The Committee may make decisions with respect to any subject matter that is subject to) Tj
0 -12 Td
(the Committee's decision-making  authority. Except as expressly provided in this) Tj
0 -12 Td
(Agreement, all decisions of the Committee) Tj
0 -12 Td
() Tj
0 -12 Td
(th  th) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-31-) Tj
0 -12 Td
() Tj
0 -12 Td
(shall be made by unanimous vote or written consent, with EKR and PPI each having,) Tj
0 -12 Td
(collectively, one vote in all decisions.  The Committee shall use commercially reasonable) Tj
0 -12 Td
(efforts to resolve the matters within its roles and functions or otherwise  referred to) Tj
0 -12 Td
(it.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(b\) If, with respect to a matter that is subject to the Committee's decision-making) Tj
0 -12 Td
(authority, the Committee cannot reach  consensus within 15 days after it has met and) Tj
0 -12 Td
(attempted to reach such consensus or the Parties cannot reach consensus  on whether the) Tj
0 -12 Td
(Committee has decision-making authority regarding a matter within 15 days after such) Tj
0 -12 Td
(matter was first  raised by either Party, the dispute in question shall be referred to the) Tj
0 -12 Td
(Chief Executive Officer of PPI, on behalf of PPI, or  such other person holding a similar) Tj
0 -12 Td
(position designated by PPI from time to time, and the Chief Executive Officer of EKR, or) Tj
0 -12 Td
(such other person holding a similar position designated by the EKR from time to time \(such) Tj
0 -12 Td
(officers collectively, the  "Executive Officers"\), for resolution. The Executive Officers) Tj
0 -12 Td
(shall use reasonable efforts to resolve the matter referred to  them.) Tj
0 -12 Td
ET
endstream
endobj
46 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 45 0 R >>
endobj
47 0 obj
<< /Length 2436 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(c\) If the Executive Officers cannot resolve the matter in accordance with Section 5.5\(b\)) Tj
0 -12 Td
(within 30 days of the reference of the  matter to them, then EKR shall have the final) Tj
0 -12 Td
(decision-making authority if the matter relates to the sale or marketing of the  Product) Tj
0 -12 Td
(in any country of the Territory and PPI shall have the final decision-making authority if) Tj
0 -12 Td
(the matter relates to the development, manufacture or Trademarks of the Product.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-32-) Tj
0 -12 Td
() Tj
0 -12 Td
(6. Fees, Milestones and Royalties.   6.1 Up-Front Payment. In consideration for work) Tj
0 -12 Td
(previously undertaken by PPI in respect of the Product, the Parties acknowledge that EKR) Tj
0 -12 Td
(has  paid a non-refundable, non-creditable up front payment of $[**] to PPI pursuant to) Tj
0 -12 Td
(the Original Agreement.   6.2 Deferred Milestone Payments. As further consideration for) Tj
0 -12 Td
(the work previously undertaken by PPI and in consideration for the license and grant of) Tj
0 -12 Td
(the Distribution Rights to EKR under this Agreement, EKR shall pay to PPI the following) Tj
0 -12 Td
(milestone payments \(the "Deferred  Milestone Payments"\) on the date when due:) Tj
0 -12 Td
() Tj
0 -12 Td
(Deferred Milestone   Due Date $[**] \(the "First Deferred Milestone"\)) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(The Parties acknowledge that EKR has paid  the First Deferred Milestone to PPI prior to) Tj
0 -12 Td
(the Agreement Date.) Tj
0 -12 Td
() Tj
0 -12 Td
($[**] \(the "Second Deferred Milestone"\)) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Within three \(3\) days of the Agreement Date,  E K R  s h a l l  p a y  t h e  S e c o n d) Tj
0 -12 Td
(D e f e r r e d   Milestone.) Tj
0 -12 Td
() Tj
0 -12 Td
(6.3 Advanced Royalty Payment to PPI.) Tj
0 -12 Td
() Tj
0 -12 Td
(\(a\) Within three \(3\) days of the Agreement Date, EKR shall make an advanced Royalty) Tj
0 -12 Td
(payment to PPI of $[**] \(the "Advanced  Royalty Payment"\), which will be offset against) Tj
0 -12 Td
ET
endstream
endobj
48 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 47 0 R >>
endobj
49 0 obj
<< /Length 3021 >>
stream
BT
/F1 10 Tf
72 720 Td
(EKR's payment obligations or otherwise repaid to EKR as set forth below  in this Section) Tj
0 -12 Td
(6.3.) Tj
0 -12 Td
() Tj
0 -12 Td
(\(b\) Offsets and/or repayment of the Advanced Royalty Payment shall commence on [**] and) Tj
0 -12 Td
(shall continue, unless sooner  paid, through [**] \(the "Royalty Offset Period"\) and such) Tj
0 -12 Td
(offsets will be taken by EKR \(and such repayment will be made  by PPI\) as follows:) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(i\) by a reduction in Royalties due under Section 6.4 of this Agreement of $[**] for each) Tj
0 -12 Td
([**] mg vial of Product sold  during the Royalty Offset Period and $[**] for each [**] mg) Tj
0 -12 Td
(Vial of Product sold during the Royalty Offset Period  \(collectively the "Royalty Offset"\)) Tj
0 -12 Td
(which amounts shall be deducted by EKR from any Royalty payments due PPI  and reflected in) Tj
0 -12 Td
(the quarterly and annual reports required in Section 6.5 of this Agreement;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-33-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(ii\) by payment to EKR of [**] percent \([**]%\) of any purchase price payments, license) Tj
0 -12 Td
(fees, other access fees or  royalties received by PPI or any of its Affiliates after the) Tj
0 -12 Td
(Agreement Date in connection with the license \(to the  extent permitted hereunder\) or) Tj
0 -12 Td
(transfer of any rights to the Product \(and/or any underlying intellectual property) Tj
0 -12 Td
(rights\) in the Field in the Territory to a Third Party \(other than pursuant to any) Tj
0 -12 Td
(transaction described in Section 6.3 \(b\)\(iii\) below\), which payment shall be made by PPI) Tj
0 -12 Td
(to EKR within ten \(10\) days of PPI's receipt of such payments;  and) Tj
0 -12 Td
() Tj
0 -12 Td
(\(iii\) upon any Change of Control \(as defined in Section 20.4\) of PPI, by repayment to EKR) Tj
0 -12 Td
(in full of the balance of the  Advanced Royalty Payment not previously used for offsets,) Tj
0 -12 Td
(which payment shall be made to EKR by PPI within ten  \(10\) days after the closing date) Tj
0 -12 Td
(\(without any conditions\) of any such Change of Control.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-34-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(c\) Notwithstanding Section 6.3\(b\), effective July 1, 2013, the balance of the Advanced) Tj
0 -12 Td
(Royalty Payment that is available for subsequent offsets and/or repayments under Section) Tj
0 -12 Td
(6.3\(b\) above shall be reduced to the lesser of \(x\) $[**] or \(y\) the  actual amount of such) Tj
0 -12 Td
(balance as calculated based upon any payments and offsets deducted to date from the) Tj
0 -12 Td
(beginning  Advanced Royalty Payment balance of $[**], as outlined in clauses \(i\) and \(ii\)) Tj
0 -12 Td
ET
endstream
endobj
50 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 49 0 R >>
endobj
51 0 obj
<< /Length 3965 >>
stream
BT
/F1 10 Tf
72 720 Td
(of Section 6.3\(b\) above. As of [**] the  balance of the Advanced Royalty Payment shall) Tj
0 -12 Td
(have been deemed repaid in full by PPI and no additional offsets to or  repayments of the) Tj
0 -12 Td
(Royalties shall thereafter be applied for any reason.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(d\) Notwithstanding anything to the contrary, in the event EKR exercises it right of) Tj
0 -12 Td
(termination pursuant to Section 16.3\(b\) of  this Agreement or PPI terminates this) Tj
0 -12 Td
(Agreement pursuant to Section 16.1\(a\): \(i\) EKR will sell the Transferred Equipment  back) Tj
0 -12 Td
(to PPI, subject to payment by PPI to EKR \(within five \(5\) days of the date of termination\)) Tj
0 -12 Td
(of $[**] in cash and  cancellation of any remaining obligation of EKR under the Promissory) Tj
0 -12 Td
(Note, \(ii\) the Advanced Royalty Payment shall be  deemed to have been repaid in full, and) Tj
0 -12 Td
(EKR shall not have the right to the Royalty Offset between the date of notice of  such) Tj
0 -12 Td
(termination and the termination date of the Agreement and \(iii\) EKR shall promptly) Tj
0 -12 Td
(transfer the Marketing  Authorizations to PPI or its nominee in accordance with Section) Tj
0 -12 Td
(17.1\(e\) below.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-35-) Tj
0 -12 Td
() Tj
0 -12 Td
(\(e\) Notwithstanding anything to the contrary, during the Royalty Offset Period, or until) Tj
0 -12 Td
(such time that the Advanced Royalty  Payment balance has been fully repaid, the combined) Tj
0 -12 Td
(Royalty and Supply Price \(as defined in the Supply Agreement\) shall  not exceed [**]) Tj
0 -12 Td
(percent \([**]%\) of the net average selling price of the Product.) Tj
0 -12 Td
() Tj
0 -12 Td
(\(f\) For the avoidance of doubt, the Royalty Offset described in clause \(i\) of Section) Tj
0 -12 Td
(6.3\(b\) shall not be applied against any Additional Royalty due PPI pursuant to Section) Tj
0 -12 Td
(6.4.   6.4 Royalties. As further consideration for the license and grant of Distribution) Tj
0 -12 Td
(Rights and other rights under this Agreement, EKR shall pay to PPI a royalty \("Royalty"\)) Tj
0 -12 Td
(equal to \(a\) $[**] for each [**] mg Vial of Product sold during the Term and $[**] for) Tj
0 -12 Td
(each [**] mg Vial of Product  sold during the Term \(the "Minimum Royalty"\)  plus \(b\) an) Tj
0 -12 Td
(additional [**]% of any post Effective Date incremental price increase  implemented by EKR) Tj
0 -12 Td
(over the Current Base Price of $[**] for the [**] mg Vial and $[**] for the [**] mg Vial) Tj
0 -12 Td
(\(the "Additional Royalty"\);  provided, however, that Additional Royalty shall not be) Tj
0 -12 Td
(payable to the extent that the sum of \(i\) the Minimum Royalty and Additional  Royalty) Tj
0 -12 Td
(payable hereunder and \(ii\) the Supply Price \(as defined in the Supply Agreement\) shall at) Tj
0 -12 Td
(any time during the Term exceed [**]  percent \([**]%\) of the net average selling price of) Tj
0 -12 Td
(the Product \(the "Royalty Cap"\); provided, however, that the Royalty Cap shall be [**]) Tj
0 -12 Td
(percent \([**]%\) of the net average selling price of the Product during certain periods as) Tj
0 -12 Td
(described in Section 6.3\(e\) above. EKR shall be  entitled to offset certain amounts from) Tj
0 -12 Td
(Royalties payable hereunder as set forth in Section 6.3\(b\) above. Royalties on other) Tj
0 -12 Td
(presentations and dosages which hereafter receive Marketing Authorization in any country) Tj
0 -12 Td
(of the Territory shall be negotiated in good faith by the  parties in a manner consistent) Tj
0 -12 Td
(with the Royalty currently being paid by EKR as of the date of the receipt of Marketing) Tj
0 -12 Td
(Authorization for  such new presentations and dosages.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
52 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 51 0 R >>
endobj
53 0 obj
<< /Length 2855 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-36-) Tj
0 -12 Td
() Tj
0 -12 Td
(6.5 Quarterly Reports and Annual Reports. Within 30 days of the end of each Quarter and) Tj
0 -12 Td
(within sixty \(60\) days of the end of each Calendar Year during the Term of this Agreement) Tj
0 -12 Td
(EKR shall send to PPI a statement setting out in respect of each country in the Territory) Tj
0 -12 Td
(in which  Product is sold, details of Product sold during the previous Quarter or Calendar) Tj
0 -12 Td
(Year, as applicable, itemized by presentation form, quantity,  total gross receipts,) Tj
0 -12 Td
(itemized deductions which are applied to achieve the Net Sales figure, and Net Sales of) Tj
0 -12 Td
(Product. The statement shall  \(where appropriate\) show:     \(a\) the total Net Sales for) Tj
0 -12 Td
(each country expressed both in local currency and in Dollars and the conversion rate used;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(b\) the total number of Vials sold in each country \(less properly rejected, returned or) Tj
0 -12 Td
(recalled Vials\) for each of the [**] mg  Product and the [**] mg Product \(the "Unit) Tj
0 -12 Td
(Sales"\);) Tj
0 -12 Td
() Tj
0 -12 Td
(\(c\) the applicable Royalty rate multiplied by the Unit Sales for each of the [**]mg and) Tj
0 -12 Td
([**] mg Products in that Quarter  \("Prepayment"\) \(or in that Calendar Year, as) Tj
0 -12 Td
(applicable\);     \(d\) any Additional Royalties due in that Quarter \(or for such Calendar) Tj
0 -12 Td
(Year\);) Tj
0 -12 Td
() Tj
0 -12 Td
(\(e\) the total Royalties payable on those Unit Sales \(subject to the Royalty Cap\) in) Tj
0 -12 Td
(accordance with Section 6.4, and any  deductions taken pursuant to Section 6.3.   6.6) Tj
0 -12 Td
(Payment. EKR shall pay to PPI, any Minimum Royalties and Additional Royalties due within) Tj
0 -12 Td
(forty-five \(45\) days of the end of each Quarter as the case may be subject to) Tj
0 -12 Td
(reconciliation at the end of each Calendar Year as set forth in Section 6.9.   6.7) Tj
0 -12 Td
(Reserved.   6.8 Reserved.   6.9 Reconciliation. Within forty-five \(45\) days of the end of) Tj
0 -12 Td
(each Contract Year, there shall be a reconciliation between the sums paid under  Section) Tj
0 -12 Td
(6.6 and the Royalties payable under Section 6.4, and any payment due \(or in the event of) Tj
0 -12 Td
(an overpayment by EKR to PPI\) such  amounts shall be paid by one Party to the other within) Tj
0 -12 Td
(thirty \(30\) days of the resolution of such reconciliation.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
54 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 53 0 R >>
endobj
55 0 obj
<< /Length 3092 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-37-) Tj
0 -12 Td
() Tj
0 -12 Td
(6.10 Withholdings. In the event that a Party is required under the laws of a country or) Tj
0 -12 Td
(other political subdivision of competent jurisdiction to withhold any tax to the tax or) Tj
0 -12 Td
(revenue authorities in such jurisdiction in connection with any payment to the other) Tj
0 -12 Td
(Party, such amount shall  be deducted from the payment to be made by such withholding) Tj
0 -12 Td
(Party; provided that the withholding Party shall take reasonable and lawful  actions to) Tj
0 -12 Td
(avoid and minimize such withholding and promptly notify the other Party so that the other) Tj
0 -12 Td
(Party may take lawful actions to avoid  and minimize such withholding. The withholding) Tj
0 -12 Td
(Party shall promptly furnish the other Party with copies of any tax certificate or other) Tj
0 -12 Td
(documentation evidencing such withholding as necessary to satisfy the requirements of the) Tj
0 -12 Td
(appropriate regulatory authority related to any  application by such other Party for) Tj
0 -12 Td
(foreign tax credit for such payment. Each Party agrees to reasonably cooperate with the) Tj
0 -12 Td
(other Party in  claiming exemptions from such deductions or withholdings under any) Tj
0 -12 Td
(agreement or treaty from time to time in effect.) Tj
0 -12 Td
() Tj
0 -12 Td
(7. Payment, Accounting, Audit Rights.   7.1 Currency. Unless otherwise agreed between the) Tj
0 -12 Td
(Parties, all payments to be made hereunder shall be made in US Dollars. Net Sales shall be) Tj
0 -12 Td
(determined in the currency in which the Product was sold and shall, if necessary, be) Tj
0 -12 Td
(converted into US Dollars using the noon buying rate  as published in the Wall Street) Tj
0 -12 Td
(Journal for the last day of the Quarter for which such payment is being determined.   7.2) Tj
0 -12 Td
(Maintenance of Records. EKR shall maintain and shall procure the maintenance of accurate) Tj
0 -12 Td
(and up to date records and books of account  showing the quantity, description and value) Tj
0 -12 Td
(of the Products supplied in each country of the Territory during the previous six \(6\)) Tj
0 -12 Td
(Calendar  Years.   7.3 Inspection. EKR shall during business hours, on no less than 14) Tj
0 -12 Td
(day's notice from PPI and not more than once in any Calendar Year, make available for) Tj
0 -12 Td
(inspection the records) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-38-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(and books referred to in Section 7.2. Such inspection shall be undertaken by an) Tj
0 -12 Td
(independent auditor appointed by PPI and reasonably  acceptable to EKR for the purpose of) Tj
0 -12 Td
(verifying the accuracy of any statement or report given by EKR to PPI and/or the amount of) Tj
0 -12 Td
ET
endstream
endobj
56 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 55 0 R >>
endobj
57 0 obj
<< /Length 4058 >>
stream
BT
/F1 10 Tf
72 720 Td
(Royalties  due. Upon completion of such inspection, PPI shall not be entitled to inspect) Tj
0 -12 Td
(nor shall EKR be required to make available the records and  books for any Calendar Year) Tj
0 -12 Td
(for which such inspection was previously undertaken.   7.4 Confidentiality. PPI shall) Tj
0 -12 Td
(procure that any independent auditor appointed under Section 7.4 shall maintain all) Tj
0 -12 Td
(information and materials  received, directly or indirectly, by it from EKR in strict) Tj
0 -12 Td
(confidence and shall not use or disclose the same to any Third Party nor to PPI save  for) Tj
0 -12 Td
(the sole purpose of conducting the audit pursuant to this Section.   7.5 Audit. In the) Tj
0 -12 Td
(event that an auditor appointed pursuant to this Section concludes that there has been an) Tj
0 -12 Td
(underpayment or overpayment, PPI shall deliver to EKR a copy of such auditor's report. Any) Tj
0 -12 Td
(deficit payable by EKR or any excess refundable by PPI shall be payable within 30  days of) Tj
0 -12 Td
(EKR's receipt of such report. The fees charged by such auditor shall be payable by PPI,) Tj
0 -12 Td
(provided that if the audit reveals that  payments due to PPI for any Calendar Year have) Tj
0 -12 Td
(been understated by more than [**]%, the fees charged by such auditor shall be payable  by) Tj
0 -12 Td
(EKR.   7.6 Interest. Should any amount not be paid by either Party on or before the due) Tj
0 -12 Td
(date for payment interest on such unpaid amount at the rate of [**]% above the prime) Tj
0 -12 Td
(lending rate of Citibank, N.A. \(or its successor in interest\) in effect from time to time) Tj
0 -12 Td
(and such interest shall be  calculated and payable in respect of the period from the date) Tj
0 -12 Td
(such amount is due until the date payment in full is received in cleared funds.) Tj
0 -12 Td
() Tj
0 -12 Td
(8. Intellectual Property and Trademarks.   8.1 Limitation of License. Except as set out in) Tj
0 -12 Td
(this Agreement, all right, title and interest in the PPI IP or Trademarks shall belong to) Tj
0 -12 Td
(PPI and EKR shall not have any right, title or interest in the PPI IP or Trademarks.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-39-) Tj
0 -12 Td
() Tj
0 -12 Td
(8.2 Trademark Standards. EKR shall use the Trademarks in a manner which conforms to the) Tj
0 -12 Td
(reasonable directions and standards notified to it  by PPI from time to time and not do) Tj
0 -12 Td
(anything which could, in the PPI's reasonable opinion, bring the Trademarks or PPI into) Tj
0 -12 Td
(disrepute or  otherwise damage the goodwill attaching to the Trademarks.   8.3 Maintenance) Tj
0 -12 Td
(of Trademarks. PPI shall, at its own cost, take all steps required to maintain those) Tj
0 -12 Td
(registrations for the Trademarks subsisting at the Effective Date, and prosecute any) Tj
0 -12 Td
(applications subsisting at the Effective Date for registration of the Trademarks through) Tj
0 -12 Td
(to grant  \(including oppositions thereto\) in each country of the Territory.   8.4) Tj
0 -12 Td
(Additional Trademark Registrations. EKR may request that PPI use reasonable efforts to) Tj
0 -12 Td
(obtain Trademark registrations in respect of the Trademarks, in classifications which) Tj
0 -12 Td
(cover the Product, in any countries in the Territory. PPI shall promptly notify EKR if it) Tj
0 -12 Td
(does not intend  to make or pursue any such Trademark registration in any of the countries) Tj
0 -12 Td
(in the Territory and EKR shall thereafter be entitled to make  applications for such) Tj
0 -12 Td
(Trademark registrations in its own name.   8.5 Domain Names. EKR shall have the right) Tj
0 -12 Td
(during the Term to register domain names in its own name specific to the countries) Tj
0 -12 Td
(comprised in  the Territory that incorporate the Trademark.   8.6 Improvements. PPI) Tj
0 -12 Td
ET
endstream
endobj
58 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 57 0 R >>
endobj
59 0 obj
<< /Length 3118 >>
stream
BT
/F1 10 Tf
72 720 Td
(Improvements shall be owned by PPI and be licensed to EKR hereunder. EKR Improvements) Tj
0 -12 Td
(shall be owned by EKR  and upon termination of this Agreement by PPI pursuant to Section,) Tj
0 -12 Td
(shall be deemed be licensed to PPI on a worldwide, non-exclusive,  irrevocable basis, at a) Tj
0 -12 Td
(royalty or for such other consideration as may be mutually agreed upon by the parties in) Tj
0 -12 Td
(writing. Joint Improvements  shall be owned jointly by the Parties, and PPI's interest) Tj
0 -12 Td
(therein shall be licensed to EKR hereunder.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-40-) Tj
0 -12 Td
() Tj
0 -12 Td
(9. Representations and Warranties.   9.1 Representations and Warranties of Both Parties.) Tj
0 -12 Td
(Each Party represents and warrants to the other Party as of the Effective Date, that:) Tj
0 -12 Td
() Tj
0 -12 Td
(\(a\) Organization. Such Party is duly organized and validly existing and in good standing) Tj
0 -12 Td
(of the laws of the jurisdiction of its  incorporation and it has full power and authority) Tj
0 -12 Td
(and legal right to enter into this Agreement and perform the obligations  under it;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(b\) Authorization. Such Party has taken all corporate action such that the execution and) Tj
0 -12 Td
(delivery of this Agreement and the  consummation of the transaction contemplated hereby) Tj
0 -12 Td
(has been duly authorized by all necessary actions;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(c\) Valid Obligation. This Agreement is a legal and valid obligation of such Party,) Tj
0 -12 Td
(binding on each of the Parties and  enforceable in accordance with its terms;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(d\) Execution and Delivery. The execution and entry into and exercise of the respective) Tj
0 -12 Td
(rights and obligations under this  Agreement including the granting of rights to the other) Tj
0 -12 Td
(Party pursuant to this Agreement do not, and will not conflict with,  or violate any) Tj
0 -12 Td
(provision of any agreement or other instrument or document to which it is Party or affect) Tj
0 -12 Td
(or be in conflict  with or result in the breach of or constitute a default under any such) Tj
0 -12 Td
(agreement, instrument or document or conflict with  any rights granted by such Party to) Tj
0 -12 Td
(any Third Party or breach any obligation that such Party has to any Third Party; and) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(e\) Debarment. It is not currently debarred, suspended or otherwise excluded by the United) Tj
0 -12 Td
(States, under any Federal law,  including, without limitation, the Generic Drug) Tj
0 -12 Td
(Enforcement Act of 1992, or by any other country in the Territory under any  analogous) Tj
0 -12 Td
(law, rule or regulation, and does not and will not use in any capacity the services of any) Tj
0 -12 Td
ET
endstream
endobj
60 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 59 0 R >>
endobj
61 0 obj
<< /Length 2643 >>
stream
BT
/F1 10 Tf
72 720 Td
(person debarred under  applicable law, rule or regulation, in the Territory in the) Tj
0 -12 Td
(performance of its obligations under this Agreement.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-41-) Tj
0 -12 Td
() Tj
0 -12 Td
(9.2 Representations and Warranties of PPI. PPI hereby represents and warrants to EKR as of) Tj
0 -12 Td
(the Effective Date that:) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(a\) Ownership; Validity. It is the owner of, or has exclusive rights to, all of the PPI IP) Tj
0 -12 Td
(and Trademarks in existence on the  Effective Date, and has the exclusive right to grant) Tj
0 -12 Td
(the Distribution Rights and other rights granted under this Agreement.  All of the PPI) Tj
0 -12 Td
(Patents in existence on the Effective Date are valid, enforceable, in full force and) Tj
0 -12 Td
(effect and have been  maintained to date and are not the subject to any interference or) Tj
0 -12 Td
(opposition procedures. All of the PPI Patents listed in the  Orange Book are properly) Tj
0 -12 Td
(filed in accordance with Applicable Laws;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(b\) Third Party Interests. There are no Third Party interests or rights in the PPI IP or) Tj
0 -12 Td
(Trademarks that may prevent, encumber or  restrict the exercise by EKR of the Distribution) Tj
0 -12 Td
(Rights or other rights granted under this Agreement.) Tj
0 -12 Td
() Tj
0 -12 Td
(\(c\) Third Party Infringement. No Third Party is infringing or has infringed the) Tj
0 -12 Td
(intellectual property rights of PPI in any of the  PPI IP or Trademarks;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(d\) Distribution Rights and other Rights. That neither the Products, the exercise of EKR's) Tj
0 -12 Td
(Distribution Rights and other rights  granted under this Agreement or the manufacture of) Tj
0 -12 Td
(the Products as contemplated by this Agreement or the Supply  Agreement do not and will) Tj
0 -12 Td
(not infringe or conflict with any Third Party intellectual property rights and EKR will) Tj
0 -12 Td
(not incur  any obligation to any Third Party by the exercise of the rights granted) Tj
0 -12 Td
(hereunder;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(e\) Renewal and Maintenance Fees. All renewal and maintenance fees and all steps necessary) Tj
0 -12 Td
(for the filing, prosecution and  maintenance of the PPI) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
62 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 61 0 R >>
endobj
63 0 obj
<< /Length 2608 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-42-) Tj
0 -12 Td
() Tj
0 -12 Td
(Patents and Trademarks due and payable as of the Effective Date have been paid or taken) Tj
0 -12 Td
(and there are no actions due  within 180 days of the Effective Date;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(f\) Trademarks. The Trademarks are the only trademarks, trade dress or service marks) Tj
0 -12 Td
(related to the Product that are owned by  PPI or licensed by PPI \(with the right to) Tj
0 -12 Td
(sublicense\);) Tj
0 -12 Td
() Tj
0 -12 Td
(\(g\) Adverse Events. To its knowledge and belief all information, data and Third Party) Tj
0 -12 Td
(notices in relation to adverse events  serious adverse events or recalls with respect to) Tj
0 -12 Td
(the Product and of which PPI is aware have been disclosed by PPI to EKR;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(h\) Access to Documents. PPI has provided EKR or given EKR access to true, complete and) Tj
0 -12 Td
(unredacted copies of all \(i\)  regulatory documentation or \(ii\) material agreements between) Tj
0 -12 Td
(PPI and any Third Party including all effective amendments  to any such agreements which) Tj
0 -12 Td
(in any event \(A\) affects or may affect EKR's rights under this Agreement or \(B\) relates to) Tj
0 -12 Td
(the Product;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(i\) No Brokers. Neither PPI nor any office, director or agent of PPI has employed any) Tj
0 -12 Td
(broker, finder or agent with respect to  this Agreement or the transactions contemplated) Tj
0 -12 Td
(hereby;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(j\) Right to License. PPI has the right to use and license PPI IP and Trademarks free and) Tj
0 -12 Td
(clear of any material liens, security,  interests, licenses, obligations, transfer) Tj
0 -12 Td
(agreements, enforceable claims or encumbrances;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(k\) Litigation. There is no litigation, arbitration, proceeding, governmental) Tj
0 -12 Td
(investigation, action or claim of any Third Party or  to the knowledge of PPI threatened) Tj
0 -12 Td
(by or against PPI relating specifically to the PPI IP, or the Trademarks which would) Tj
0 -12 Td
(impede, impair, restrict or interfere with the rights granted EKR hereunder or the ability) Tj
0 -12 Td
(of PPI to perform its obligations  hereunder; and) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
64 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 63 0 R >>
endobj
65 0 obj
<< /Length 2746 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-43-) Tj
0 -12 Td
() Tj
0 -12 Td
(\(l\) Customer Lists. PPI has or prior to the Effective Date will have provided EKR with) Tj
0 -12 Td
(complete and accurate lists of the names  and addresses of all material customers and) Tj
0 -12 Td
(suppliers of the Products.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(m\) Permits. PPI has and shall maintain at all times during the Term all necessary) Tj
0 -12 Td
(license, permits, records and authorizations  required by Applicable Laws necessary to) Tj
0 -12 Td
(perform its obligations hereunder and shall observe and comply with all  Applicable Laws,) Tj
0 -12 Td
(ordinances, rules and regulations including those of the applicable Regulatory Authorities) Tj
0 -12 Td
(and  governmental entities including but not limited to DEA in the performance of its) Tj
0 -12 Td
(obligations hereunder.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(n\) ICS Agreement. All amounts due under the ICS Agreement as of or prior to the Effective) Tj
0 -12 Td
(Date have been paid in full. PPI is  not in, nor has PPI given or received notice of, any) Tj
0 -12 Td
(default or claimed, purported or alleged default, or facts that, with notice  or lapse of) Tj
0 -12 Td
(time, or both, would constitute a default \(or give rise to a termination right\) on the) Tj
0 -12 Td
(part of any person in the performance of any obligation to be performed under the ICS) Tj
0 -12 Td
(Agreement. A true and complete copy of the ICS Agreement,  including any amendments) Tj
0 -12 Td
(thereto, has been delivered to EKR.) Tj
0 -12 Td
() Tj
0 -12 Td
(10. Liability, Insurance and Indemnities   10.1 Indemnification of EKR. PPI shall be) Tj
0 -12 Td
(liable for and shall defend, indemnify and hold harmless EKR and its Affiliates and their) Tj
0 -12 Td
(officers, directors, agents, representatives, consultants and employees \(individually an) Tj
0 -12 Td
("EKR Indemnified Party"  and collectively the "EKR  Indemnified Parties"\) and any of them) Tj
0 -12 Td
(from and against any and all Claims \(as defined below\), arising in connection with or) Tj
0 -12 Td
(relating to:) Tj
0 -12 Td
() Tj
0 -12 Td
(\(a\) The development, manufacture, sale and supply of the Product prior to the Effective) Tj
0 -12 Td
(Date \(including Claims arising after the  Effective Date to the extent they are based on) Tj
0 -12 Td
(events occurring prior to the Effective Date\);) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
66 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 65 0 R >>
endobj
67 0 obj
<< /Length 2380 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-44-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(b\) The manufacture of the Product by or on behalf of PPI \(including, but not limited to,) Tj
0 -12 Td
(any manufacture of Product or any  other product by EKR for the Other PPI Customers) Tj
0 -12 Td
(pursuant to Section 3.20\(l\)\) except to the extent that such Claims arise  from \(i\) the) Tj
0 -12 Td
(negligence or willful misconduct of EKR or its Affiliates, \(ii\) the breach by EKR of the) Tj
0 -12 Td
(terms of this Agreement  or \(iii\) the manufacture of Product by EKR in accordance with) Tj
0 -12 Td
(EKR's exercise Step-in Right for supply of Product to EKR or  its Affiliates;     \(c\)) Tj
0 -12 Td
(Claims which arise outside the Territory \(except to the extent that the Claim has arisen) Tj
0 -12 Td
(from any act or omission by EKR\);) Tj
0 -12 Td
() Tj
0 -12 Td
(\(d\) A breach by PPI of any representation, warranty, covenant or agreement contained in) Tj
0 -12 Td
(this Agreement, the Supply  Agreement or the Transition Services and Inventory Agreement;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(e\) PPI's failure to comply with any Applicable Law in connection with the performance of) Tj
0 -12 Td
(its obligations hereunder or under  the Supply Agreement or the Transition Services and) Tj
0 -12 Td
(Inventory Agreement, or prior to the Effective Date; and     \(f\) Any Claims related to) Tj
0 -12 Td
(Product sold by parties other than EKR prior or subsequent to the Effective Date.) Tj
0 -12 Td
() Tj
0 -12 Td
(\(g\) Liabilities arising under the ICS Agreement prior to the Effective Date and subsequent) Tj
0 -12 Td
(to the Effective Date for Products  sold by parties other than EKR or under the direction) Tj
0 -12 Td
(of EKR or arising under the Transition Services and Inventory  Agreement.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-45-) Tj
0 -12 Td
() Tj
0 -12 Td
(10.2 Indemnification of PPI. EKR shall be liable for and shall defend, indemnify and hold) Tj
0 -12 Td
ET
endstream
endobj
68 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 67 0 R >>
endobj
69 0 obj
<< /Length 4009 >>
stream
BT
/F1 10 Tf
72 720 Td
(harmless PPI from and against any and all Claims  arising from \(i\) EKR's exercise of the) Tj
0 -12 Td
(Distribution Rights or arising under the Transition Services and Inventory Agreement, \(ii\)) Tj
0 -12 Td
(a breach by  EKR of any representation, warranty, covenant or agreement contained in this) Tj
0 -12 Td
(Agreement, the Supply Agreement or the Transitions  Services and Inventory Agreement, or) Tj
0 -12 Td
(\(iii\) EKR's failure to comply with Applicable Laws in connection with its performance of) Tj
0 -12 Td
(its  obligations hereunder, or \(iv\) Claims related to the manufacture of Products by EKR) Tj
0 -12 Td
(or by a Third Party Manufacturer designated by EKR  pursuant to Section 11.5 of the Supply) Tj
0 -12 Td
(Agreement, except to the extent that such Claims:     \(a\) relate to any act or) Tj
0 -12 Td
(circumstance occurring prior to the Effective Date;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(b\) relate to Intellectual Property infringement proceedings with Third Parties in) Tj
0 -12 Td
(connection with the PPI IP and Trademarks  \(except to the extent that the Claim has arisen) Tj
0 -12 Td
(from EKR's use of the PPI IP or Trademarks other than in accordance with  this Agreement\);) Tj
0 -12 Td
(\(c\) arise outside the Territory \(except to the extent that the Claim has arisen from any) Tj
0 -12 Td
(act or omission by EKR\);     \(d\) relate to the development or manufacture of the Product) Tj
0 -12 Td
(by PPI or its Affiliates or its or their agents or sub-contractors;     \(e\) Arise under) Tj
0 -12 Td
(the ICS Agreement after the Effective Date for Products sold by EKR.) Tj
0 -12 Td
() Tj
0 -12 Td
(\(f\) result from the negligence, willful default or material breach of any representation) Tj
0 -12 Td
(or warranty given under this Agreement,  the Supply Agreement, or the Transition Services) Tj
0 -12 Td
(and Inventory Agreement by PPI, its Affiliates or sub-contractors; or     \(g\) are the) Tj
0 -12 Td
(responsibility of PPI under Section 10.1 above.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-46-) Tj
0 -12 Td
() Tj
0 -12 Td
(10.3 Conditions to Indemnification. Promptly after receipt by a Party of any Claim or) Tj
0 -12 Td
(alleged claim or notice of the commencement of any action, administrative or legal) Tj
0 -12 Td
(proceeding, or investigation as to which the indemnity provided for in this Section 10 may) Tj
0 -12 Td
(apply, the indemnified  Party shall give written notice to the indemnifying Party of such) Tj
0 -12 Td
(fact. The indemnifying Party shall have the option to assume the defense  thereof by) Tj
0 -12 Td
(election in writing within thirty \(30\) days of receipt of such notice. If the indemnifying) Tj
0 -12 Td
(Party fails to make such election, the  indemnified Party may assume such defense and the) Tj
0 -12 Td
(indemnifying Party will be liable for reasonable legal and other expenses subsequently) Tj
0 -12 Td
(incurred in connection with such defense. The Parties will co-operate in good faith in the) Tj
0 -12 Td
(conduct of any defense, provide such reasonable  assistance as may be required to enable) Tj
0 -12 Td
(any Claim to be properly defended, and the Party with conduct of the action shall provide) Tj
0 -12 Td
(promptly  to the other Party copies of all proceedings relating to such action.   10.4) Tj
0 -12 Td
(Assumption of Defense. Should the indemnifying Party assume conduct of the defense:) Tj
0 -12 Td
() Tj
0 -12 Td
(\(a\) the indemnified Party may retain separate legal advisors in the event that it) Tj
0 -12 Td
(reasonably concludes that it may have defenses  available to it which are additional to,) Tj
0 -12 Td
(different from or inconsistent with those available to the indemnifying Party, in which) Tj
0 -12 Td
(case the indemnifying Party shall not be liable for the indemnified Party's reasonable) Tj
0 -12 Td
ET
endstream
endobj
70 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 69 0 R >>
endobj
71 0 obj
<< /Length 3478 >>
stream
BT
/F1 10 Tf
72 720 Td
(costs and expenses so incurred; and) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(b\) the indemnifying Party will not, except with the consent of the indemnified Party) Tj
0 -12 Td
(\(such consent not be unreasonably  withheld or delayed\), consent to the entry of any) Tj
0 -12 Td
(judgment or enter into any settlement \(other than for the payment of  damages by the) Tj
0 -12 Td
(indemnifying Party, which includes as an unconditional term a release from the claimant to) Tj
0 -12 Td
(the indemnified  Party from all liability in respect of all claims\).) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-47-) Tj
0 -12 Td
() Tj
0 -12 Td
(10.5 Settlement of Claims. The indemnified Party shall not admit liability in respect of,) Tj
0 -12 Td
(or compromise or settle any such action without the prior  written consent of the) Tj
0 -12 Td
(indemnifying Party, such consent not to be unreasonably withheld or delayed.   10.6) Tj
0 -12 Td
(Insurance. Each Party shall maintain, at its own cost, comprehensive product liability) Tj
0 -12 Td
(insurance, general commercial liability insurance and business interruption insurance at a) Tj
0 -12 Td
(level which is reasonable and customary taking into account the nature of the Product but) Tj
0 -12 Td
(which shall  have combined limits of not less than $[**] per occurrence. Such insurance) Tj
0 -12 Td
(shall be with a reputable insurance company and where  reasonably possible \(taking into) Tj
0 -12 Td
(account the availability of such insurance\) shall be maintained for not less than [**]) Tj
0 -12 Td
(\([**]\) years following  the expiry or termination of this Agreement. During the Term,) Tj
0 -12 Td
(neither Party shall do or omit to do any act, matter or thing which could  prejudice or) Tj
0 -12 Td
(render voidable any such insurance. Each Party will provide to the other Party evidence of) Tj
0 -12 Td
(its insurance and thirty \(30\) days  prior written notice of any cancellation of its) Tj
0 -12 Td
(coverage or reduction in coverage from the requirements stated herein.   10.7 Third Party) Tj
0 -12 Td
(Liability. Each of the Parties shall be liable to the other for legal liability to Third) Tj
0 -12 Td
(Parties in respect of all claims, actions,  judgments, damages, lawsuits, costs or) Tj
0 -12 Td
(expenses or professional fees for death or personal injury incurred by such other Party in) Tj
0 -12 Td
(relation to  or arising out of any breach of this Agreement, the Transition Services and) Tj
0 -12 Td
(Inventory Agreement or the Supply Agreement by the first  Party or of any gross negligence) Tj
0 -12 Td
(or willful act of the first Party, or its employees in the course of their employment.) Tj
0 -12 Td
(10.8 PPI Liability Limitation. Any and all liability of PPI to EKR howsoever arising in) Tj
0 -12 Td
(respect of this Agreement, the Transition Services and Inventory Agreement or the Supply) Tj
0 -12 Td
(Agreement and their performance, in contract tort or otherwise, shall be limited \(except) Tj
0 -12 Td
(for death or  personal injury caused by the negligence of PPI or its employees while) Tj
0 -12 Td
(acting in the course of their employment\) to [**] US Dollars \($[**]\);  provided) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
72 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 71 0 R >>
endobj
73 0 obj
<< /Length 3219 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-48-) Tj
0 -12 Td
() Tj
0 -12 Td
(however that such limitation shall not apply to the extent that EKR or any EKR Indemnified) Tj
0 -12 Td
(Party is required to pay in excess of such  amount to a third party in respect of a final) Tj
0 -12 Td
(judgment or order obtained by the third party or as a result of PPI's breach of Section) Tj
0 -12 Td
(7.2.12 of  the Supply Agreement.   10.9 EKR Liability Limitation. Any and all liability of) Tj
0 -12 Td
(EKR to PPI howsoever arising in respect of this Agreement, the Transition Services and) Tj
0 -12 Td
(Inventory Agreement or the Supply Agreement and their performance in contract tort or) Tj
0 -12 Td
(otherwise shall be limited \(except for death or  personal injury caused by the negligence) Tj
0 -12 Td
(of EKR or its employees while acting in the course of their employment, and except in) Tj
0 -12 Td
(relation to  any specified payment, lump sum, milestone or royalty payment unpaid\) to [**]) Tj
0 -12 Td
(US Dollars \($[**]\); provided however that such limitation  shall not apply to the extent) Tj
0 -12 Td
(that PPI or any PPI Indemnified Party is required to pay in excess of such amount to a) Tj
0 -12 Td
(third party in respect of a  final judgment or order obtained by the third party.   10.10) Tj
0 -12 Td
(Limitation of Damages. Notwithstanding anything contained in this Agreement or the) Tj
0 -12 Td
(Transition Services and Inventory Agreement or the  Supply Agreement in no circumstance) Tj
0 -12 Td
(shall either Party be liable to the other in contract, tort \(including negligence or) Tj
0 -12 Td
(breach of statutory  duty\) or otherwise howsoever, and whatever the cause thereof, for any) Tj
0 -12 Td
(special, indirect or consequential loss or damage of any nature  whatsoever except in the) Tj
0 -12 Td
(cases of fraud or intentional misconduct or in the case of PPI as a result of PPI's breach) Tj
0 -12 Td
(of Section 7.2.12 of the  Supply Agreement.   10.11 Definition of Claims. In this Section) Tj
0 -12 Td
(10, "Claims" shall mean any and all claims, actions, demands, losses, damages, costs and) Tj
0 -12 Td
(reasonable  expenses \(including, without limitation, reasonable legal and expert fees\)) Tj
0 -12 Td
(made or brought by Third Parties.) Tj
0 -12 Td
() Tj
0 -12 Td
(11. Confidentiality, Press Releases and Publications   11.1 Confidential Information. PPI) Tj
0 -12 Td
(and EKR undertake to each other to keep confidential, and to procure that their respective) Tj
0 -12 Td
(Affiliates, employees, directors, officers, contractors, lawyers and accountants) Tj
0 -12 Td
(\(including those of their Affiliates\) keep confidential, Confidential  Information) Tj
0 -12 Td
(disclosed to it by or belonging to the other Party.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-49-) Tj
0 -12 Td
() Tj
0 -12 Td
(11.2 Third Party Disclosure. Any Confidential Information received from the other Party) Tj
0 -12 Td
ET
endstream
endobj
74 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 73 0 R >>
endobj
75 0 obj
<< /Length 3827 >>
stream
BT
/F1 10 Tf
72 720 Td
(shall not be disclosed to any Third Party or used for  any purpose other than as provided) Tj
0 -12 Td
(or specifically envisaged by this Agreement or as required in connection with any) Tj
0 -12 Td
(securities offering,  financing, merger, acquisition or other corporate transaction) Tj
0 -12 Td
(involving such Party provided that any Party to whom such disclosure is made  is bound by) Tj
0 -12 Td
(obligations as to confidentiality that are at least as protective of Confidential) Tj
0 -12 Td
(Information as those contained herein.   11.3 Duration. The confidentiality and non-use) Tj
0 -12 Td
(obligations contained in this Agreement shall continue for the duration of this Agreement) Tj
0 -12 Td
(and  for a period of [**] \([**]\) years after termination for any reason of this Agreement.) Tj
0 -12 Td
(11.4 Public Announcements. The Parties shall consult with each other, in advance, with) Tj
0 -12 Td
(regard to the terms of all proposed press releases,  public announcements and other public) Tj
0 -12 Td
(statements with respect to the transactions contemplated under this Agreement. The Parties) Tj
0 -12 Td
(acknowledge that they have issued a joint press release in the form set out in Schedule VI) Tj
0 -12 Td
(of this Agreement.   11.5 Exceptions to Disclosure of Confidential Information. The) Tj
0 -12 Td
(Confidential Information may be disclosed by the other Parties to the extent that such) Tj
0 -12 Td
(disclosure has been ordered by a court of law or directed by a governmental authority,) Tj
0 -12 Td
(provided that, wherever practicable, the Party  disclosing the Confidential Information) Tj
0 -12 Td
(has been given sufficient written notice in advance to the other Party to enable it to) Tj
0 -12 Td
(seek protection  or confidential treatment of such Confidential Information, and may be) Tj
0 -12 Td
(disclosed only to the extent that such disclosure has been so  ordered or directed.) Tj
0 -12 Td
() Tj
0 -12 Td
(12. Patents   12.1 Maintenance. PPI shall pay all costs and expenses of the filing,) Tj
0 -12 Td
(prosecution and maintenance of the PPI Patents in each country of the Territory so as to) Tj
0 -12 Td
(maintain the) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-50-) Tj
0 -12 Td
() Tj
0 -12 Td
(PPI Patents in full force and effect. PPI will consult with EKR with respect to any notice) Tj
0 -12 Td
(from or correspondence with the USPTO or any  other governmental entity with respect) Tj
0 -12 Td
(thereto and the development, filing and prosecution of any subdivisions, continuations,) Tj
0 -12 Td
(continuations in part or additional applications related to the Product for use in the) Tj
0 -12 Td
(Field in the Territory.) Tj
0 -12 Td
() Tj
0 -12 Td
(13. Infringement of Third Party Rights  13.1 Notice of Infringement. In the event of a) Tj
0 -12 Td
(Party becoming aware that the exercise of either Party's rights and obligations pursuant) Tj
0 -12 Td
(to this  Agreement are infringing or may infringe the rights of a Third Party, it will) Tj
0 -12 Td
(promptly notify the other Party and provide it with such details  of the Third Party) Tj
0 -12 Td
(rights and the extent of the infringement as are known to it.   13.2 Infringement of Third) Tj
0 -12 Td
(Party IP. In the event a claim of infringement of a Third Party's intellectual property) Tj
0 -12 Td
(rights arising out of the manufacture, use, sale, promotion or distribution of the) Tj
0 -12 Td
(Products is brought against either Party, PPI shall defend such action at its cost  and) Tj
0 -12 Td
(expense and take one or more of the following actions simultaneously or sequentially:) Tj
0 -12 Td
ET
endstream
endobj
76 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 75 0 R >>
endobj
77 0 obj
<< /Length 3518 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
(\(a\) Defend the claim and indemnify and hold harmless EKR, its Affiliates, officers,) Tj
0 -12 Td
(directors, shareholders, employees,  representations, consultants and agents \(the "EKR) Tj
0 -12 Td
(Infringement Indemnitees"\) as set forth in Section 13.3 below.) Tj
0 -12 Td
() Tj
0 -12 Td
(\(b\) Obtain for itself as the benefit of EKR the right through license or otherwise to) Tj
0 -12 Td
(utilize the technology upon which the claim  of infringement was based. Such rights) Tj
0 -12 Td
(obtained by PPI from a Third Party under this Section 13.2 shall be licensed or) Tj
0 -12 Td
(sublicensed to EKR at no additional cost to EKR.   13.3 Infringement Indemnification.) Tj
0 -12 Td
(Notwithstanding any other provisions of this Agreement, PPI will defend, indemnify and) Tj
0 -12 Td
(hold harmless the  EKR Infringement) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-51-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Indemnitees from and against all liabilities, losses, damages, actions, claims and) Tj
0 -12 Td
(expenses suffered or incurred by the EKR Infringement  Indemnitees \(including reasonable) Tj
0 -12 Td
(attorneys fees, court costs and expert witnesses' fees\) resulting from any claims by any) Tj
0 -12 Td
(Third Party that  EKR's exercise during the Term of the rights granted under this) Tj
0 -12 Td
(Agreement infringes or violates any license, patent, copyright, trademark or  other) Tj
0 -12 Td
(intellectual property right of that Third Party.) Tj
0 -12 Td
() Tj
0 -12 Td
(14. Infringement of PPI IP  14.1 Notice of Infringement. In the event that either Party) Tj
0 -12 Td
(becomes aware of any actual or suspected infringement or misuse of the PPI IP or) Tj
0 -12 Td
(Trademarks in the Territory by a Third Party \("Third Party Infringement"\), it shall) Tj
0 -12 Td
(promptly notify the other Party and provide it with all  details thereof in its) Tj
0 -12 Td
(possession.   14.2 Infringement Action. Within a reasonable time of becoming aware of such) Tj
0 -12 Td
(Third Party Infringement, the Parties shall consult with each  other and their respective) Tj
0 -12 Td
(counsel to develop a strategy for addressing the Third Party Infringement. In the event) Tj
0 -12 Td
(the Parties agree to the  legal action to stop the Third Party Infringement, they shall) Tj
0 -12 Td
(agree upon legal counsel to prosecute such action and unless the Parties  otherwise agree,) Tj
0 -12 Td
(PPI shall prosecute the action at its cost and expense. EKR shall provide all such) Tj
0 -12 Td
(assistance at PPI's cost and expense as  PPI may reasonably require in the prosecution or) Tj
0 -12 Td
(defense of any such proceedings.   14.3 Awards. Any damages, award or settlement monies) Tj
0 -12 Td
(actually received by PPI in respect to such infringement and paid in compensation for) Tj
0 -12 Td
(sales lost by EKR shall be deemed Net Sales and be paid to EKR, subject to PPI deducting) Tj
0 -12 Td
(its costs and expenses in pursuing such  infringement from such damages, award or) Tj
0 -12 Td
(settlement actually received. Any damages, award or settlement monies actually received by) Tj
0 -12 Td
(PPI  in respect to such infringement and not paid in compensation for sales lost by EKR) Tj
0 -12 Td
(shall be shared equally by the Parties.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
78 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 77 0 R >>
endobj
79 0 obj
<< /Length 3166 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-52-) Tj
0 -12 Td
() Tj
0 -12 Td
(14.4 Non Participation. Should in accordance with Section 14.2, PPI decide not to) Tj
0 -12 Td
(participate in any such infringement action, EKR may require  PPI to bring the action,) Tj
0 -12 Td
(subject to reimbursement by EKR for reasonable out-of-pocket expenses incurred by PPI in) Tj
0 -12 Td
(connection with such  action. The selection of counsel and all other material decisions) Tj
0 -12 Td
(with respect to such action shall be subject to EKR's prior, written  approval, such) Tj
0 -12 Td
(approval not to be unreasonably withheld. In addition, EKR shall have the right to) Tj
0 -12 Td
(discontinue the prosecution of any such  action at any time upon written notice to PPI.) Tj
0 -12 Td
(Except as provided above in this Section 14.4, PPI shall have control of such action but) Tj
0 -12 Td
(shall  consult with EKR regarding the conduct of such action and shall not settle such) Tj
0 -12 Td
(action without the prior written consent of EKR, which  consent shall not be unreasonably) Tj
0 -12 Td
(withheld, and EKR may, in such instance, retain any award or settlement in its entirety.) Tj
0 -12 Td
(Notwithstanding  the foregoing, PPI shall offer reasonable assistance to EKR at no charge) Tj
0 -12 Td
(except for reimbursement of reasonable out of pocket expense  including reasonable) Tj
0 -12 Td
(attorneys fees.   14.5 Cooperation. Each Party shall keep the other Party reasonably) Tj
0 -12 Td
(informed and consult with the other Party with regard to any infringement action under) Tj
0 -12 Td
(this Article 14.) Tj
0 -12 Td
() Tj
0 -12 Td
(15. Term   15.1 This Agreement shall commence on the Effective Date and, subject to) Tj
0 -12 Td
(earlier termination in accordance with the provisions of Section 16, shall continue in) Tj
0 -12 Td
(force for a period being the longer of fifteen \(15\) years from first Commercial Launch of) Tj
0 -12 Td
(the Product in the Territory or until  the expiration of the last valid claim in the PPI) Tj
0 -12 Td
(Patents covering the Product in any country of the Territory \(the "Initial Term"\).) Tj
0 -12 Td
(Thereafter  the term of this Agreement shall automatically renew for consecutive periods) Tj
0 -12 Td
(of two \(2\) years each. Notwithstanding the foregoing, this  Agreement can be terminated by) Tj
0 -12 Td
(EKR at the end of the Initial Term by delivery of written notice to PPI at least one) Tj
0 -12 Td
(hundred eighty \(180\)  days prior to the end of the Initial Term or any renewal term. As) Tj
0 -12 Td
(used herein "Term" refers to the Initial Term and any renewal terms.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-53-) Tj
0 -12 Td
() Tj
0 -12 Td
(16. Termination   16.1 Prior Termination by Either Party. Either Party shall be entitled) Tj
0 -12 Td
(forthwith to terminate this Agreement by notice to the other if:) Tj
0 -12 Td
ET
endstream
endobj
80 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 79 0 R >>
endobj
81 0 obj
<< /Length 2585 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
(\(a\) the other Party commits a material breach of any material obligation under this) Tj
0 -12 Td
(Agreement or the Supply Agreement, and in  the case of a breach which is capable of remedy) Tj
0 -12 Td
(fails to remedy it within sixty \(60\) days of receipt of notice from the first  Party of) Tj
0 -12 Td
(such breach and of its intention to exercise its rights under this Section; or) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(b\) any representation or warranty made herein or in the Supply Agreement by such other) Tj
0 -12 Td
(Party proves to be incorrect when  made which has a material adverse effect on the) Tj
0 -12 Td
(performance of the other Party's obligations hereunder and in the case of a  breach which) Tj
0 -12 Td
(is capable of remedy fails to remedy it within sixty \(60\) days of receipt of notice from) Tj
0 -12 Td
(the first Party of such  breach and of its intention to exercise its rights under this) Tj
0 -12 Td
(Section; or) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(c\) the entry of a decree or order for relief by a court having jurisdiction in the) Tj
0 -12 Td
(premises in respect of the other Party in an  involuntary case under the United States) Tj
0 -12 Td
(Bankruptcy Code, as now constituted or hereafter amended, or any other  applicable) Tj
0 -12 Td
(foreign, federal or state insolvency or other similar law and the continuance of any such) Tj
0 -12 Td
(decree or order  unstayed and in effect for a period of sixty \(60\) consecutive days; or) Tj
0 -12 Td
() Tj
0 -12 Td
(\(d\) the filing by the other Party of a petition for relief under the United States) Tj
0 -12 Td
(Bankruptcy Code, as now constituted or  hereafter amended, or any other applicable) Tj
0 -12 Td
(foreign, federal or state insolvency law or other similar law; or) Tj
0 -12 Td
() Tj
0 -12 Td
(\(e\) the other Party becomes insolvent or takes the benefit of any statute for insolvent) Tj
0 -12 Td
(debtors or any steps are taken or  proceedings commenced by any person for the) Tj
0 -12 Td
(dissolution, winding-up or other termination of such other Party's existence  or the) Tj
0 -12 Td
(liquidation of its assets; or) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-54-) Tj
0 -12 Td
ET
endstream
endobj
82 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 81 0 R >>
endobj
83 0 obj
<< /Length 2984 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
(\(f\) a trustee, receiver, receiver-manager or like person is appointed with respect to the) Tj
0 -12 Td
(business or assets of the other Party; or) Tj
0 -12 Td
() Tj
0 -12 Td
(\(g\) the other Party proposes or makes any composition or arrangement or composition with,) Tj
0 -12 Td
(or any assignment for the benefit  of, its creditors; or) Tj
0 -12 Td
() Tj
0 -12 Td
(\(h\) anything analogous to any of the events described in Sections 16.1\(c\)-\(k\) - 16.1.6,) Tj
0 -12 Td
(inclusive, occurs under the laws of any applicable jurisdiction; or     \(i\) the other) Tj
0 -12 Td
(Party ceases or threatens to cease to carry on the whole or any material part of its) Tj
0 -12 Td
(business; or) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(j\) for reasons unrelated to any breach of either Parties' duties or obligations under or) Tj
0 -12 Td
(in connection with this Agreement, the  other Party is prevented from performing any of) Tj
0 -12 Td
(its material obligations hereunder by any law, governmental or other action  \(other than) Tj
0 -12 Td
(laws of general application\) and has not resumed performance in compliance with all) Tj
0 -12 Td
(Applicable Laws within  one hundred twenty \(120\) days following the date on which such) Tj
0 -12 Td
(performance was first provided; or     \(k\) in accordance with Section 18.2 below.   16.2) Tj
0 -12 Td
(Prior Termination by PPI.     \(a\) Reserved.) Tj
0 -12 Td
() Tj
0 -12 Td
(\(b\) PPI may terminate this Agreement with immediate effect in any country of the Territory) Tj
0 -12 Td
(where EKR is obligated to launch  the Product pursuant to Section 4.5 if within [**]) Tj
0 -12 Td
(months of the receipt of the Marketing Authorization for such country,  EKR has not made) Tj
0 -12 Td
(its first Commercial Launch of the Product in that country.) Tj
0 -12 Td
() Tj
0 -12 Td
(\(c\) In the event PPI has terminated the Supply Agreement pursuant to Section 10.2 thereof) Tj
0 -12 Td
(and EKR or its designee is  manufacturing Products pursuant to Section 11.5 of the Supply) Tj
0 -12 Td
(Agreement, PPI shall have the right to terminate such rights  of manufacture and this) Tj
0 -12 Td
(Agreement upon thirty \(30\)) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-55-) Tj
0 -12 Td
() Tj
0 -12 Td
(days prior, written notice to EKR only in the event Royalties and Additional Royalties) Tj
0 -12 Td
(paid hereunder in any one year  period following the date of such termination are less) Tj
0 -12 Td
(than $[**], unless the difference between $[**] and the actual  Royalties and Additional) Tj
0 -12 Td
(Royalties paid by EKR is paid to PPI within thirty \(30\) days of notice of such) Tj
0 -12 Td
(termination.   16.3 Prior Termination by EKR.) Tj
0 -12 Td
ET
endstream
endobj
84 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 83 0 R >>
endobj
85 0 obj
<< /Length 3480 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
(\(a\) EKR may terminate this Agreement with immediate effect in any country of the Territory) Tj
0 -12 Td
(if the Products are withdrawn from  the market in such country of the Territory as a) Tj
0 -12 Td
(result of regulatory action by FDA or other governmental entities or there  are) Tj
0 -12 Td
(significant adverse reactions from use of the Products.     \(b\) EKR may terminate this) Tj
0 -12 Td
(Agreement for convenience at any time upon [**] \([**]\) days prior, written notice to PPI.) Tj
0 -12 Td
(16.4 Effect of Termination. The termination or expiration of this Agreement shall not) Tj
0 -12 Td
(release either of the Parties from any liability which at the  time of termination or) Tj
0 -12 Td
(expiry has already accrued to the other Party, nor affect in any way the survival of any) Tj
0 -12 Td
(other right, duty or obligation  of the Parties which is expressly stated elsewhere in) Tj
0 -12 Td
(this Agreement to survive such termination or expiry.) Tj
0 -12 Td
() Tj
0 -12 Td
(17. Consequences of Termination   17.1 Upon termination of this Agreement for any reason) Tj
0 -12 Td
(except as set forth in Section 17.4 below \(and, if applicable, in respect of that country) Tj
0 -12 Td
(in  respect of which termination occurs\):) Tj
0 -12 Td
() Tj
0 -12 Td
(\(a\) the licenses and rights granted and appointments made under Sections 2.1, 2.2 and 2.3) Tj
0 -12 Td
(shall terminate and EKR shall \(and  shall procure that its Affiliates, sub-distributors) Tj
0 -12 Td
(and sub-licensees shall\) cease all activities licensed or appointed  hereunder, subject to) Tj
0 -12 Td
(Sections 17.2 and 17.3;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-56-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(b\) the following provisions of this Agreement shall continue in full force and effect:) Tj
0 -12 Td
(Article 1 \("Definitions"\), Section 3.20\(k\),  Section 3.20\(l\), Article 9 \("Representations) Tj
0 -12 Td
(and Warranties"\), Article 10 \("Liability, Insurance and Indemnities"\) \(excluding  Section) Tj
0 -12 Td
(10.6 \("Insurance"\)\), Article 11 \("Confidentiality, Press Releases and Publications"\),) Tj
0 -12 Td
(Article 13 \("Infringement of  Third Party Rights"\), Section 16.4 \("Effect of) Tj
0 -12 Td
(Termination"\), Article 17 \("Consequences of Termination"\), Article 18 \("Force  Majeure"\),) Tj
0 -12 Td
(Article 19 \("Notices"\), Article 20 \("Assignment and Change of Control"\) and Article 21) Tj
0 -12 Td
(\("General Provisions"\);     \(c\) EKR shall return to PPI all PPI IP in its possession;) Tj
0 -12 Td
(\(d\) EKR shall assign to PPI free of charge any domain name registrations it has registered) Tj
0 -12 Td
(pursuant to Section 8.5; and) Tj
0 -12 Td
() Tj
0 -12 Td
(\(e\) Except in the event of termination of this Agreement by EKR pursuant to Section) Tj
0 -12 Td
(16.1\(a\), EKR shall promptly transfer to PPI  or its nominee, each and every Marketing) Tj
0 -12 Td
(Authorization \(to the extent not held by PPI\) relating to the Product, together  with all) Tj
0 -12 Td
(communications with the relevant Regulatory Authorities, and all notes and record thereof.) Tj
0 -12 Td
(17.2 Sale of Remaining Inventory. Where this Agreement has expired or has been terminated) Tj
0 -12 Td
ET
endstream
endobj
86 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 85 0 R >>
endobj
87 0 obj
<< /Length 3684 >>
stream
BT
/F1 10 Tf
72 720 Td
(for any reason other than by PPI in accordance  with Section 16.1 or EKR in accordance) Tj
0 -12 Td
(with Section 16.3\(b\), EKR and its Affiliates and sub-distributors and sales agents shall) Tj
0 -12 Td
(be entitled  to continue to sell existing stocks of the Product in the Territory for a) Tj
0 -12 Td
(period of not longer than 12 months following the date of termination,  provided that, EKR) Tj
0 -12 Td
(continues to make any Royalty payments due to PPI in respect of such sales in accordance) Tj
0 -12 Td
(with the provisions of this  Agreement.   17.3 Other Rights upon Termination. In the event) Tj
0 -12 Td
(that this Agreement is terminated by PPI in accordance with Section 16.1 or EKR in) Tj
0 -12 Td
(accordance with Section 16.3\(b\), EKR and its Affiliates, sub-distributors and sub-) Tj
0 -12 Td
(licensees shall be entitled to continue to sell) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-57-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(existing stocks of the Product in the Territory for so long as PPI deems necessary to) Tj
0 -12 Td
(ensure that sale of the Product is not disrupted  provided that EKR and its Affiliates) Tj
0 -12 Td
(shall cease such sale immediately upon notification from PPI and in any event EKR shall) Tj
0 -12 Td
(not so sell for  a period of longer than three \(3\) months following the date of) Tj
0 -12 Td
(termination. Immediately upon notification from PPI, such post termination  sales shall) Tj
0 -12 Td
(cease.   17.4 Other Remedies of EKR. Notwithstanding anything contained herein to the) Tj
0 -12 Td
(contrary, in the event that EKR is entitled to exercise its right to terminate this) Tj
0 -12 Td
(Agreement pursuant to Section 16.1\(a\), in addition to the right to terminate as provided) Tj
0 -12 Td
(therein and any other remedies EKR  may have hereunder, PPI shall assist EKR in the) Tj
0 -12 Td
(transfer of the manufacture of the Products, including the Specifications from PPI to EKR) Tj
0 -12 Td
(or EKR's designee. In such event, the Royalty payments payable hereunder shall continue to) Tj
0 -12 Td
(be paid; provided,  however, that all costs  incurred by EKR in the transfer of) Tj
0 -12 Td
(manufacturing information from PPI and obtaining FDA approval of the manufacture of the) Tj
0 -12 Td
(Products by  EKR or EKR's designee, and any other amounts due to EKR, shall be deducted) Tj
0 -12 Td
(from any royalties payable to PPI. In addition, PPI shall  during the remainder of the) Tj
0 -12 Td
(Term and for a period of up to [**] \([**]\) years thereafter continue to manufacture and) Tj
0 -12 Td
(supply the Product to  EKR at cost without mark-up until such time that EKR can secure an) Tj
0 -12 Td
(FDA approved manufacturing facility for the Product. PPI shall provide such advice as) Tj
0 -12 Td
(necessary for EKR to arrange for an alternative manufacturer and shall provide EKR with) Tj
0 -12 Td
(access to all relevant PPI  Know-How, and any other information necessary for EKR to) Tj
0 -12 Td
(transfer such manufacturing to an alternate manufacturer. In addition, \(i\) PPI  shall) Tj
0 -12 Td
(transfer to EKR any Marketing Authorizations held by PPI and \(ii\) the Trademark license) Tj
0 -12 Td
(granted under Section 2.3 shall continue in  effect following such termination on a) Tj
0 -12 Td
(perpetual basis and EKR shall be responsible for all costs associated with the maintenance) Tj
0 -12 Td
(of such  Trademark.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
88 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 87 0 R >>
endobj
89 0 obj
<< /Length 3251 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-58-) Tj
0 -12 Td
() Tj
0 -12 Td
(17.5 EKR Step-In Rights.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(a\) During the Term, in the event EKR has the right to terminate this Agreement under) Tj
0 -12 Td
(Section 16.1\(a\) - \(i\) hereof \(the "Step-in  Right Trigger Event"\), and EKR does not) Tj
0 -12 Td
(exercise its right to terminate this Agreement under such Section, EKR shall  have the) Tj
0 -12 Td
(option to exercise step-in rights to manufacture the Product for the remainder of the Term) Tj
0 -12 Td
(\(the "Step-in Right"\) by  providing PPI written notice of such election within ninety \(90\)) Tj
0 -12 Td
(days after the Step-in Right Trigger Event \(or such longer  period as mutually agreed by) Tj
0 -12 Td
(the Parties\) \(the "Step-in Right Notice"\); provided that in the event such Step-in Right) Tj
0 -12 Td
(Trigger Event has been cured prior to EKR's exercise of the Step-in Right, the Step-in) Tj
0 -12 Td
(Right shall terminate with respect to  such Step-in Right Trigger Event. The Step-in Right) Tj
0 -12 Td
(Notice shall specify the date which EKR intends to exercise the rights  associated with) Tj
0 -12 Td
(the Step-in Right.) Tj
0 -12 Td
() Tj
0 -12 Td
(\(b\) In the event EKR exercises the Step-in Right, PPI shall, at EKR's cost and expense,) Tj
0 -12 Td
(cooperate in the exercise of such rights  and EKR shall reimburse PPI for the reasonable) Tj
0 -12 Td
(costs PPI incurs in assisting EKR in the exercise of such rights within thirty  \(30\) days) Tj
0 -12 Td
(of EKR's receipt of invoice.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(c\) The Step-in Right shall include, without limitation, and to the extent allowable under) Tj
0 -12 Td
(Applicable Law, PPI's grant to EKR of  such additional license rights, rights of access,) Tj
0 -12 Td
(rights of observation and rights of management, direction and control, in  each case) Tj
0 -12 Td
(solely with respect to the manufacture and supply of Product and as reasonably necessary) Tj
0 -12 Td
(to enable and permit  EKR \(or EKR's designee\) to ensure that the supply of Product shall) Tj
0 -12 Td
(continue to be available to EKR under this Agreement  and the Supply Agreement; provided) Tj
0 -12 Td
(that EKR in exercising the Step-in Right shall not \(i\) unreasonably interfere with PPI's) Tj
0 -12 Td
(other activities at the facilities at which the Product is manufactured, tested, labeled,) Tj
0 -12 Td
(stored or) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-59-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(otherwise handled \("Product Facilities"\) or \(ii\) require PPI to take any action or fail to) Tj
0 -12 Td
(take any action that does or could  reasonably be expected to interfere with PPI's other) Tj
0 -12 Td
(activities at the Product Facilities. The foregoing rights shall apply  with respect to) Tj
0 -12 Td
(any Product Facility to the extent necessary for EKR to preserve and protect supply of the) Tj
0 -12 Td
(Product as  contemplated by this Agreement and the Supply Agreement. For the avoidance of) Tj
0 -12 Td
ET
endstream
endobj
90 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 89 0 R >>
endobj
91 0 obj
<< /Length 3632 >>
stream
BT
/F1 10 Tf
72 720 Td
(doubt, \(i\) upon termination of the Lease  Term, PPI shall maintain responsibility and) Tj
0 -12 Td
(control over all other products manufactured by PPI and nothing in this Section  17.5) Tj
0 -12 Td
(shall give EKR any rights to direct, manage or control the manufacture of such products) Tj
0 -12 Td
(\(ii\) PPI shall maintain  responsibility and control over the facilities where Product is) Tj
0 -12 Td
(manufactured, tested, labeled, stored or otherwise handled  and nothing in this Section) Tj
0 -12 Td
(17.5 shall give EKR general oversight or control of the facilities where Product is) Tj
0 -12 Td
(manufactured,  tested, labeled, stored or otherwise handled.) Tj
0 -12 Td
() Tj
0 -12 Td
(\(d\) In the event EKR exercises the Step-in Right, EKR shall comply with all policies) Tj
0 -12 Td
(applicable to the facilities where Product is  manufactured, tested, labeled, stored or) Tj
0 -12 Td
(otherwise handled and all Applicable Laws with respect to the manufacture of the  Product.) Tj
0 -12 Td
() Tj
0 -12 Td
(18. Force Majeure   18.1 Obligation to Perform. Except for payment obligations which shall) Tj
0 -12 Td
(not be excused or affected by any Force Majeure, neither Party shall be entitled to) Tj
0 -12 Td
(terminate this Agreement or shall be liable to the other under this Agreement for loss or) Tj
0 -12 Td
(damages attributable to any Force  Majeure, provided the Party affected shall give prompt) Tj
0 -12 Td
(notice thereof to the other Party. Subject to Section 18.2, the Party giving such  notice) Tj
0 -12 Td
(shall be excused from such of its obligations hereunder for so long as it continues to be) Tj
0 -12 Td
(affected by Force Majeure.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-60-) Tj
0 -12 Td
() Tj
0 -12 Td
(18.2 Duration. If such Force Majeure continues unabated for a period of at least ninety) Tj
0 -12 Td
(\(90\) days, the Parties will meet to discuss in good faith  what actions to take or what) Tj
0 -12 Td
(modifications should be made to this Agreement as a consequence of such Force Majeure in) Tj
0 -12 Td
(order to alleviate  its consequences on the affected Party. If the affected Party is) Tj
0 -12 Td
(prevented by reason of any circumstances referred to in this Section of this  Agreement) Tj
0 -12 Td
(from performing any of its obligations hereunder for a continuous period of six \(6\) months) Tj
0 -12 Td
(the other Party may terminate this  Agreement.) Tj
0 -12 Td
() Tj
0 -12 Td
(19. Notices   19.1 Form. Any notice or other document given under this Agreement shall be) Tj
0 -12 Td
(in writing in the English language and shall be given by hand or  sent by U.S. prepaid) Tj
0 -12 Td
(first class registered or certified mail, return receipt requested, recognized national) Tj
0 -12 Td
(overnight courier service, or by fax  transmission to the address of the receiving Party) Tj
0 -12 Td
(as set out in Section 19.3 below unless a different address or fax number has been) Tj
0 -12 Td
(notified to the other in writing for this purpose.   19.2 Delivery. Each such notice or) Tj
0 -12 Td
(document shall:     \(a\) if sent by hand, be deemed to have been given when delivered at) Tj
0 -12 Td
(the relevant address;     \(b\) if sent by prepaid airmail, be deemed to have been given 7) Tj
0 -12 Td
(days after posting; or) Tj
0 -12 Td
() Tj
0 -12 Td
(\(c\) if sent by fax transmission be deemed to have been given when transmitted provided) Tj
0 -12 Td
ET
endstream
endobj
92 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 91 0 R >>
endobj
93 0 obj
<< /Length 2155 >>
stream
BT
/F1 10 Tf
72 720 Td
(that a confirmatory copy of such  facsimile transmission shall have been sent by hand,) Tj
0 -12 Td
(U.S. prepaid first class registered or certified mail, return receipt  requested, or) Tj
0 -12 Td
(recognized national overnight courier service within 24 hours of such transmission.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-61-) Tj
0 -12 Td
() Tj
0 -12 Td
(19.3 Notice of Parties. The address for services of notices and other documents on the) Tj
0 -12 Td
(Parties shall be:) Tj
0 -12 Td
() Tj
0 -12 Td
(To EKR   To PPI) Tj
0 -12 Td
() Tj
0 -12 Td
(Address:) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(1545 Route 206 South  Third Floor  Bedminster, NJ 07921) Tj
0 -12 Td
() Tj
0 -12 Td
(Address:) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(10450 Science Center  Drive, San Diego,  California 92121 USA) Tj
0 -12 Td
() Tj
0 -12 Td
(Fax:     Fax:   858 623 0376) Tj
0 -12 Td
() Tj
0 -12 Td
(Attention:   Chairman & CEO   Attention:   President) Tj
0 -12 Td
() Tj
0 -12 Td
(With a copy to:   With a copy to:) Tj
0 -12 Td
() Tj
0 -12 Td
(Lowenstein Sandler  65 Livingston Avenue  Roseland, New Jersey 07068) Tj
0 -12 Td
() Tj
0 -12 Td
(Wilmer Cutler Pickering Hale & Dorr LLP  1117 S California Avenue  Palo Alto, CA 94304 USA) Tj
0 -12 Td
() Tj
0 -12 Td
(Fax:    973-597-6395   Fax:   650-858-6100  Attention:   Michael J. Lerner   Attention:) Tj
0 -12 Td
(Joseph K. Wyatt) Tj
0 -12 Td
() Tj
0 -12 Td
(20. Assignment and Change of Control   20.1 Assignment. Subject to Section 20.2, neither) Tj
0 -12 Td
(Party shall, nor shall it purport to, assign, license, transfer or change any of its) Tj
0 -12 Td
(rights or  obligations under this Agreement without the prior written consent of the) Tj
0 -12 Td
(other, such consent not to be unreasonably withheld  conditioned or delayed; provided,) Tj
0 -12 Td
(however, that except as provided in Section 20.4 either Party may assign its rights) Tj
0 -12 Td
ET
endstream
endobj
94 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 93 0 R >>
endobj
95 0 obj
<< /Length 3340 >>
stream
BT
/F1 10 Tf
72 720 Td
(hereunder to an  Affiliate or to any successor by merger, consolidation, sale of stock or) Tj
0 -12 Td
(other equity interests or the sale of substantially all of the assets of  such Party) Tj
0 -12 Td
(without the consent of the other Party. For the avoidance of doubt, either Party may grant) Tj
0 -12 Td
(a security interest with respect to its  rights under this Agreement in connection with a) Tj
0 -12 Td
(secured financing or similar transaction.   20.2 Sub-Distribution. EKR may appoint sub-) Tj
0 -12 Td
(distributors under this Agreement provided that EKR:) Tj
0 -12 Td
() Tj
0 -12 Td
(\(a\) informs PPI of the identity of any Third Party sub-distributor \(other than Affiliate) Tj
0 -12 Td
(companies\) prior to the execution of any  sub-distribution agreement;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-62-) Tj
0 -12 Td
() Tj
0 -12 Td
(\(b\) obtain a confidential nondisclosure agreement with the prospective Sub-Distributor in) Tj
0 -12 Td
(a form acceptable to PPI, which  acceptance shall not be unreasonably withheld or delayed) Tj
0 -12 Td
(and containing terms at least as stringent as those terms  included in Article 11 of this) Tj
0 -12 Td
(Agreement;) Tj
0 -12 Td
() Tj
0 -12 Td
(\(c\) deliver to the prospective Sub-Distributor a redacted copy of this Agreement) Tj
0 -12 Td
(\("Redacted Agreement"\) .  Any sub- distribution agreement shall provide that such) Tj
0 -12 Td
(agreement is subject and subordinate to the rights of PPI under this  Agreement; and) Tj
0 -12 Td
() Tj
0 -12 Td
(\(d\) provides PPI with a copy of written sub-distribution agreement as soon as reasonably) Tj
0 -12 Td
(practicable after the execution  thereof by EKR.   20.3 Responsibility of EKR.) Tj
0 -12 Td
(Notwithstanding any such sub-distribution agreement, EKR shall remain primarily liable to) Tj
0 -12 Td
(PPI for its obligations hereunder, and for any act or omission of any sub-distributor.) Tj
0 -12 Td
(20.4 Change of Control. Should there be a Change of Control of either Party resulting in) Tj
0 -12 Td
(the control of such Party by a Third Party which  markets or sells a Competing Product in) Tj
0 -12 Td
(any part of the Territory, then the rights under this Agreement may not be assigned) Tj
0 -12 Td
(without the  express consent of the other Party which consent shall not be unreasonably) Tj
0 -12 Td
(withheld. "Change of Control" shall mean \(a\) the sale, lease,  exchange, license or) Tj
0 -12 Td
(disposition of all or substantially all of the Party's assets in one transaction or series) Tj
0 -12 Td
(of related transactions or \(b\) a  merger or consolidation with an unaffiliated Third Party) Tj
0 -12 Td
(as a result of which the holders of the Party's issued and outstanding voting  securities) Tj
0 -12 Td
(immediately before such transaction own or control less than a majority of the voting) Tj
0 -12 Td
(securities of the continuing or surviving  entity immediately after such transaction. The) Tj
0 -12 Td
(issuance by either Party of securities in connection with any financing transaction or) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
96 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 95 0 R >>
endobj
97 0 obj
<< /Length 3238 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-63-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(public offering shall not be deemed a Change of Control under this Agreement.) Tj
0 -12 Td
(Notwithstanding the foregoing, for the purposes of Section  6.3\(b\)\(iii\): \(i\) references to) Tj
0 -12 Td
(a "Party" in the above definition of Change of Control shall be deemed to include PPI as) Tj
0 -12 Td
(well as any Affiliate of  PPI and \(ii\) a Change of Control shall also include \(in addition) Tj
0 -12 Td
(to any of the transactions described above in the definition of Change of  Control\), any) Tj
0 -12 Td
(sale of securities of PPI or its Affiliates directly by the holder \(the "Holder"\) of such) Tj
0 -12 Td
(securities \(other than to an Affiliate of  such Holder\) in which such sale results in a) Tj
0 -12 Td
(transfer of more than 50% of the outstanding voting stock of PPI or its Affiliates.) Tj
0 -12 Td
() Tj
0 -12 Td
(21. General Provisions   21.1 Relationship of the Parties. Nothing in this agreement is) Tj
0 -12 Td
(deemed to constitute a partnership, agency, employer-employee or joint venture) Tj
0 -12 Td
(relationship between the Parties. No Party shall incur any debts or make any commitments) Tj
0 -12 Td
(for the other, except to the extent, if at all,  specifically provided herein.   21.2) Tj
0 -12 Td
(Dispute Resolution. If there is a disagreement between the PPI and EKR on the) Tj
0 -12 Td
(interpretation of this Agreement or any aspect of the performance by either Party of its) Tj
0 -12 Td
(obligations under this Agreement, the Parties shall resolve the dispute in accordance with) Tj
0 -12 Td
(the dispute  resolution procedure set out in Schedule VIII.   21.3 Cooperation. Each of) Tj
0 -12 Td
(the Parties shall do execute and perform and shall procure to be done executed and) Tj
0 -12 Td
(performed all such further acts  deeds documents and things as the other Party may) Tj
0 -12 Td
(reasonably require from time to time to give full effect to the terms of this Agreement.) Tj
0 -12 Td
(21.4 Expenses. Each Party shall pay its own costs, charges and expenses incurred in) Tj
0 -12 Td
(connection with the negotiation, preparation and  completion of this agreement.   21.5) Tj
0 -12 Td
(Entire Agreement. This Agreement \(together with the Transition Services and Inventory) Tj
0 -12 Td
(Purchase Agreement and the Supply Agreement\)  sets out the entire agreement and) Tj
0 -12 Td
(understanding between the Parties in respect of the subject matter hereof and thereof.) Tj
0 -12 Td
(This Agreement  supersedes the Original Agreement and any heads of agreement which shall) Tj
0 -12 Td
(cease to have any further force or effect. It is agreed that:) Tj
0 -12 Td
() Tj
0 -12 Td
(\(a\) no Party has entered into this Agreement in reliance upon any representation, warranty) Tj
0 -12 Td
(or undertaking of the other Party  which is not expressly set out in this Agreement;) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
98 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 97 0 R >>
endobj
99 0 obj
<< /Length 3308 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-64-) Tj
0 -12 Td
() Tj
0 -12 Td
(\(b\) no Party shall have any remedy in respect of misrepresentation or untrue statement) Tj
0 -12 Td
(made by the other Party or for any  breach of warranty which is not contained in this) Tj
0 -12 Td
(Agreement;     \(c\) this Section shall not exclude any liability for, or remedy in respect) Tj
0 -12 Td
(of, fraudulent misrepresentation.   21.6 Amendment. No amendment, change or modification) Tj
0 -12 Td
(of any of the terms, provisions or conditions of this Agreement shall be valid unless it) Tj
0 -12 Td
(is in writing and signed by or on behalf of both Parties.   21.7 Waiver. Unless expressly) Tj
0 -12 Td
(agreed, no waiver of any term, provision or condition of this Agreement shall constitute a) Tj
0 -12 Td
(general waiver of any provisions of this Agreement, nor shall it affect any rights,) Tj
0 -12 Td
(obligations or liabilities under or pursuant to this Agreement which have  already accrued) Tj
0 -12 Td
(up to the date of variation, and the rights and obligations of the Parties under or) Tj
0 -12 Td
(pursuant to this Agreement shall remain in  full force and effect, except and only to the) Tj
0 -12 Td
(extent that they are so waived.   21.8 Unenforceability. If and to the extent that any) Tj
0 -12 Td
(provision of this Agreement is held to be illegal, void or unenforceable, such provision) Tj
0 -12 Td
(shall  be given no effect and shall be deemed not to be included in this Agreement but) Tj
0 -12 Td
(without invalidating any of the remaining provisions of  this Agreement.   21.9 Delay. No) Tj
0 -12 Td
(failure or delay by either Party in exercising any right or remedy provided by law under) Tj
0 -12 Td
(or pursuant to this Agreement shall  impair such right or remedy or operate or be) Tj
0 -12 Td
(construed as a waiver or variation of it or preclude its exercise at any subsequent time) Tj
0 -12 Td
(and no  single or partial exercise of any such right or remedy shall preclude any other or) Tj
0 -12 Td
(further exercise of it or the exercise of any other right or  remedy.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(signature page follows\)      -65-) Tj
0 -12 Td
() Tj
0 -12 Td
(21.10 Cumulative Rights. The rights and remedies of each of the Parties under or pursuant) Tj
0 -12 Td
(to this Agreement are cumulative, may be exercised as often as such Party considers) Tj
0 -12 Td
(appropriate and are in addition to its rights and remedies under general law.   21.11) Tj
0 -12 Td
(Counterparts. This Agreement may be executed in any number of counterparts and by the) Tj
0 -12 Td
(Parties on separate counterparts, each of which  is an original but all of which together) Tj
0 -12 Td
(constitute one and the same instrument.   21.12 Reserved.   21.13 Governing Law. This) Tj
0 -12 Td
(Agreement and the relationship between the Parties shall be governed by, and interpreted) Tj
0 -12 Td
(in accordance with New  York law without regard to provisions related to conflicts of) Tj
0 -12 Td
ET
endstream
endobj
100 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 99 0 R >>
endobj
101 0 obj
<< /Length 3043 >>
stream
BT
/F1 10 Tf
72 720 Td
(laws, and, except as provided in Section 21.2 above, the Parties agree to submit  any) Tj
0 -12 Td
(dispute to the exclusive jurisdiction of the federal and state courts sitting in New York.) Tj
0 -12 Td
(21.14 Successors and Assigns. Subject to Section 20.1, this Agreement shall be binding) Tj
0 -12 Td
(upon and shall inure to the benefit of the Parties hereto  and their respective successors) Tj
0 -12 Td
(and assigns permitted under this Agreement.   21.15 Systems. Immediately upon the) Tj
0 -12 Td
(Effective Date, or as soon thereafter as practicable, the Parties shall implement a) Tj
0 -12 Td
(mutually acceptable operation plan to transfer the processing of chargebacks, federal) Tj
0 -12 Td
(releases, state releases and customer services from PPI to EKR.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(AS WITNESS the hands of the Parties or their duly authorized representatives effective as) Tj
0 -12 Td
(of the Effective Date.) Tj
0 -12 Td
() Tj
0 -12 Td
(-66-) Tj
0 -12 Td
() Tj
0 -12 Td
(SIGNED for and by behalf of   \)   By:  /s/ David Stack  PACIRA PHARMACEUTICALS, INC.) Tj
0 -12 Td
(\)         David Stack      Print Name) Tj
0 -12 Td
() Tj
0 -12 Td
(SIGNED for and by behalf of   \)   By:  /s/ Richard DeSimone  EKR THERAPEUTICS, INC.) Tj
0 -12 Td
(Richard DeSimone, CFO      Print Name) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(SCHEDULE I) Tj
0 -12 Td
() Tj
0 -12 Td
(PATENTS) Tj
0 -12 Td
() Tj
0 -12 Td
(-67-) Tj
0 -12 Td
() Tj
0 -12 Td
([**] Attorneys'  Ref:   Country   Application  date   Application  no.   Patent/) Tj
0 -12 Td
(Publication no.   Grant date   Expiry date   Status  [**]   [**]   [**]   [**]   [**]) Tj
0 -12 Td
([**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]) Tj
0 -12 Td
([**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]) Tj
0 -12 Td
([**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]) Tj
0 -12 Td
() Tj
0 -12 Td
([**] Attorneys'  Ref:   Country   Application  date   Application  no.   Patent/) Tj
0 -12 Td
(Publication no.   Grant date   Expiry date   Status  [**]   [**]   [**]   [**]   [**]) Tj
0 -12 Td
([**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]) Tj
0 -12 Td
([**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]) Tj
0 -12 Td
([**]) Tj
0 -12 Td
() Tj
0 -12 Td
([**]) Tj
0 -12 Td
() Tj
0 -12 Td
(Attorneys'  Ref:   Country   Application  date   Application  no.) Tj
0 -12 Td
() Tj
0 -12 Td
(Patent/  Publication  no.   Grant date   Expiry date   Status  [**]   [**]   [**]   [**]) Tj
0 -12 Td
([**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]) Tj
0 -12 Td
([**]   [**]   [**]         [**]  [**]   [**]             [**]  [**]   [**]   [**]   [**]) Tj
0 -12 Td
([**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]) Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
102 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 101 0 R >>
endobj
103 0 obj
<< /Length 2383 >>
stream
BT
/F1 10 Tf
72 720 Td
([**] Attorneys'  Ref:   Country   Application  date   Application  no.   Patent/) Tj
0 -12 Td
(Publication no.   Grant date   Expiry date   Status  [**]   [**]   [**]   [**]   [**]) Tj
0 -12 Td
([**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]) Tj
0 -12 Td
([**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]         [**]) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-68-) Tj
0 -12 Td
() Tj
0 -12 Td
([**]) Tj
0 -12 Td
() Tj
0 -12 Td
(Attorneys'  Ref:   Country   Application  date   Application  no.) Tj
0 -12 Td
() Tj
0 -12 Td
(Patent/  Publication  no.   Grant date   Expiry date   Status  [**]   [**]   [**]   [**]) Tj
0 -12 Td
([**]     [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  * Publication) Tj
0 -12 Td
(date of Application - 13 Apr 06.) Tj
0 -12 Td
() Tj
0 -12 Td
([**] Attorneys'  Ref:   Country   Application  date   Application  no.   Patent/) Tj
0 -12 Td
(Publication no.   Grant date   Expiry date   Status  [**]   [**]   [**]   [**]   [**]) Tj
0 -12 Td
([**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]) Tj
0 -12 Td
([**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]) Tj
0 -12 Td
([**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(SCHEDULE II   TRADEMARKS) Tj
0 -12 Td
() Tj
0 -12 Td
([**] - Owner of Record, United States Patent Trademark Office website. Record of) Tj
0 -12 Td
(Assignment from [**]. to [**] is in process.      -69-) Tj
0 -12 Td
() Tj
0 -12 Td
(File Date: Serial No.: International Class: First Use: First Use in Commerce: Registration) Tj
0 -12 Td
(Date: Registration No.: Mark:) Tj
0 -12 Td
() Tj
0 -12 Td
([**]) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(File Date: Serial No.: International Class: First Use: First Use in Commerce: Registration) Tj
0 -12 Td
(Date: Registration No.: Mark:) Tj
0 -12 Td
() Tj
0 -12 Td
([**]) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(File Date: Serial No.: International Class: First Use: First Use in Commerce: Registration) Tj
0 -12 Td
(Date: Registration No.: Mark:) Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
104 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 103 0 R >>
endobj
105 0 obj
<< /Length 1326 >>
stream
BT
/F1 10 Tf
72 720 Td
([**]) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(*[**] Trademark Application) Tj
0 -12 Td
() Tj
0 -12 Td
(File Date: Serial No.: International Class: Mark:) Tj
0 -12 Td
() Tj
0 -12 Td
([**]) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(SCHEDULE III) Tj
0 -12 Td
() Tj
0 -12 Td
(COPYRIGHTS) Tj
0 -12 Td
() Tj
0 -12 Td
(There are no recorded copyrights      -70-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(SCHEDULE IV) Tj
0 -12 Td
() Tj
0 -12 Td
(DOMAIN NAMES) Tj
0 -12 Td
() Tj
0 -12 Td
(DepoDur.com      -71-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(SCHEDULE V) Tj
0 -12 Td
() Tj
0 -12 Td
(MARKETING AUTHORIZATIONS) Tj
0 -12 Td
() Tj
0 -12 Td
(United States Food and Drug Administration New Drug Application: [**]      -72-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(News Release) Tj
0 -12 Td
() Tj
0 -12 Td
(EKR Therapeutics Achieves Key Growth Milestone with the   Acquisition of Rights to DepoDur) Tj
0 -12 Td
(, a Novel Extended-Release Opioid   Analgesic for Post Operative Pain) Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
106 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 105 0 R >>
endobj
107 0 obj
<< /Length 3862 >>
stream
BT
/F1 10 Tf
72 720 Td
(Cedar Knolls, N.J., August X, 2007 - EKR Therapeutics, Inc., a specialty pharmaceutical) Tj
0 -12 Td
(company focused on acquiring, developing, and  commercializing proprietary products to) Tj
0 -12 Td
(enhance patient quality-of-life in the acute care setting, today announced it has acquired) Tj
0 -12 Td
(exclusive  marketing and distribution rights to DepoDur  for the Americas from San Diego-) Tj
0 -12 Td
(based Pacira Pharmaceuticals who retains manufacturing rights to  the product.) Tj
0 -12 Td
() Tj
0 -12 Td
(Formerly a business unit of SkyePharma, plc, Pacira Pharmaceuticals is an independent) Tj
0 -12 Td
(private company focused on developing and   manufacturing controlled-release injectable) Tj
0 -12 Td
(products based on their DepoFoam  and Biosphere  drug delivery platforms.) Tj
0 -12 Td
() Tj
0 -12 Td
(DepoDur, which utilizes the DepoFoam technology, is a sterile injectable suspension of) Tj
0 -12 Td
(multivesicular liposomes formulated to provide extended  release of morphine sulfate. It) Tj
0 -12 Td
(is the only extended-release opioid that is approved by the Food and Drug Administration) Tj
0 -12 Td
(for epidural use. A single  injection of DepoDur into the lumbar epidural space may) Tj
0 -12 Td
(provide pain relief for up to 48 hours following major surgery without the restrictions) Tj
0 -12 Td
(and  potential complications associated with an indwelling epidural catheter.) Tj
0 -12 Td
() Tj
0 -12 Td
("The product characteristics of DepoDur fit exceptionally well with EKR's acquisition) Tj
0 -12 Td
(model," said Howard Weisman, EKR's Chairman & CEO.  "DepoDur is patent protected,) Tj
0 -12 Td
(addresses an important medical need in our market space, and has growth prospects that can) Tj
0 -12 Td
(be fully exploited through the application of EKR's expertise and strengths in the acute) Tj
0 -12 Td
(care market.") Tj
0 -12 Td
() Tj
0 -12 Td
(Mr. Weisman further noted, "EKR is commencing a number of pre-launch activities, including) Tj
0 -12 Td
(interacting with opinion leaders, and we expect to  fully deploy our sales force in) Tj
0 -12 Td
(support of DepoDur early next year." He concluded, "We are very optimistic about EKR's) Tj
0 -12 Td
(growth prospects in 2008  as we foresee a ramp up in sales for both DepoDur and Gelclair) Tj
0 -12 Td
(and anticipate favorable market synergies between these products." Gelclair,  which is) Tj
0 -12 Td
(marketed to acute care facilities and cancer centers, is indicated for the management of) Tj
0 -12 Td
(pain associated with oral lesions of various  etiologies, including chemotherapy and) Tj
0 -12 Td
(radiation induced oral mucositis/stomatitis.) Tj
0 -12 Td
() Tj
0 -12 Td
(Tong Zhang, Ph.D., Director of Business Development for EKR, added, "Acquiring the rights) Tj
0 -12 Td
(to DepoDur exemplifies EKR's strategy of focusing  on building a portfolio of premier) Tj
0 -12 Td
(products in the acute care space."  He further noted, "Our strict acquisition criteria) Tj
0 -12 Td
(center on high-margin,  innovative products that offer value to healthcare providers and) Tj
0 -12 Td
(their patients, thus, representing excellent opportunities for EKR to realize strong) Tj
0 -12 Td
(returns on investment."      -73-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(SCHEDULE VI) Tj
0 -12 Td
() Tj
0 -12 Td
(PRESS RELEASE) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
("Pacira Pharmaceuticals is delighted to have EKR Therapeutics as our marketing and) Tj
0 -12 Td
(commercialization partner for DepoDur in the Americas,"  commented Fred Middleton,) Tj
0 -12 Td
(Pacira's Chairman of the Board. "This product was clinically developed as a proprietary) Tj
0 -12 Td
(treatment by Pacira R&D and  it received FDA approval in 2004 for long-acting post) Tj
0 -12 Td
ET
endstream
endobj
108 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 107 0 R >>
endobj
109 0 obj
<< /Length 3506 >>
stream
BT
/F1 10 Tf
72 720 Td
(surgical pain management, for which it is known to be effective.") Tj
0 -12 Td
() Tj
0 -12 Td
(Mr. Middleton further noted, "EKR Therapeutics has demonstrated in the past that they) Tj
0 -12 Td
(possess the strengths to successfully bringing a focused  marketing and clinician) Tj
0 -12 Td
(targeting approach to DepoDur to help it reach its full commercial potential. We look) Tj
0 -12 Td
(forward to working with EKR, as our  partner on the expanded commercial marketing of) Tj
0 -12 Td
(DepoDur.") Tj
0 -12 Td
() Tj
0 -12 Td
(Detailed terms of the transaction were not disclosed. However, EKR did note that in) Tj
0 -12 Td
(addition to royalty payments on net sales, it has agreed to an  upfront payment amounting) Tj
0 -12 Td
(to somewhat more than [**] times DepoDur's 2006 U.S. sales. EKR has also agreed to certain) Tj
0 -12 Td
(milestone payments with the sum of upfront and milestone payments potentially worth up to) Tj
0 -12 Td
($20 million.) Tj
0 -12 Td
() Tj
0 -12 Td
(About EKR Therapeutics   EKR Therapeutics is a privately held specialty pharmaceutical) Tj
0 -12 Td
(company that has brought together a highly seasoned team of industry professionals The) Tj
0 -12 Td
(Company focuses on the acquisition, development and commercialization of proprietary) Tj
0 -12 Td
(products for the acute care segment of  the healthcare market, including oncology) Tj
0 -12 Td
(supportive care therapeutics. From its inception in late 2005, EKR has been organized to) Tj
0 -12 Td
(be a class  leader in commercializing products to address unmet and under-satisfied) Tj
0 -12 Td
(medical needs or to otherwise enhance the therapeutic value of acute-care  prescription) Tj
0 -12 Td
(products. EKR's goal is to be the pre-eminent provider of acute-care specialty products,) Tj
0 -12 Td
(backed by a commitment to excellence in  customer service. For additional information) Tj
0 -12 Td
(about EKR visit the Company's website at http://www.ekrtx.com.) Tj
0 -12 Td
() Tj
0 -12 Td
(About Pacira Pharmaceuticals, Inc.   Pacira Pharmaceuticals, Inc. is a wholly owned) Tj
0 -12 Td
(subsidiary of Pacira Inc., a Delaware corporation, which is controlled and funded by a) Tj
0 -12 Td
(group of  financial investors including Sanderling Ventures, HBM Bioventures \(Cayman\) Ltd,) Tj
0 -12 Td
(OrbiMed Advisors, and MPM Capital. This business is based  in San Diego, CA, and focuses) Tj
0 -12 Td
(on formulating, developing and manufacturing controlled-release injectable products based) Tj
0 -12 Td
(on two proprietary  drug delivery platforms: DepoFoam  and Biosphere . Revenues are) Tj
0 -12 Td
(generated from two marketed products: DepoCyt  for lymphomatous  meningitis and DepoDur) Tj
0 -12 Td
(for the treatment of post-surgical pain. For additional information about Pacira visit the) Tj
0 -12 Td
(Company's website at  http://www.pacira.com) Tj
0 -12 Td
() Tj
0 -12 Td
(####) Tj
0 -12 Td
() Tj
0 -12 Td
(Contact for EKR Therapeutics   Stuart Z. Levine, Ph.D.   Corporate Communications) Tj
0 -12 Td
(877-435-2524   s.levine@ekrtx.com      -74-) Tj
0 -12 Td
() Tj
0 -12 Td
(TM TM) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(SCHEDULE VII) Tj
0 -12 Td
() Tj
0 -12 Td
(THE TERRITORY) Tj
0 -12 Td
() Tj
0 -12 Td
(all countries in North America including the United States, its territories as possessions) Tj
0 -12 Td
(including Puerto Rico, South America and Central America     -75-) Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
110 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 109 0 R >>
endobj
111 0 obj
<< /Length 3022 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(SCHEDULE VIII) Tj
0 -12 Td
() Tj
0 -12 Td
(DISPUTE RESOLUTION) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Appointment of an Expert) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-76-) Tj
0 -12 Td
() Tj
0 -12 Td
(1.1 Representatives of the Parties will, within 14 days of receipt of a written request) Tj
0 -12 Td
(from either Party to the other, convene a meeting of the Committee to discuss in good) Tj
0 -12 Td
(faith and try to resolve the disagreement without recourse to legal proceedings.   1.2 If) Tj
0 -12 Td
(resolution does not occur within 7 days after meeting, the matter shall be escalated for) Tj
0 -12 Td
(determination by the respective Chief Executive  Officer of the Parties who may resolve) Tj
0 -12 Td
(the matter themselves or jointly appoint a mediator or independent expert to do so.   1.3) Tj
0 -12 Td
(Nothing in this Agreement restricts either Party's freedom to seek urgent relief to) Tj
0 -12 Td
(preserve a legal right or remedy, or to protect a proprietary, trade secret or other) Tj
0 -12 Td
(right.) Tj
0 -12 Td
() Tj
0 -12 Td
(1.4.1 In the event that the Chief Executive Officers are unable to resolve the dispute and) Tj
0 -12 Td
(the dispute has a monetary value of cost of [**] dollars \($[**]\) or more, the dispute) Tj
0 -12 Td
(shall be submitted to the federal or state courts located in the State of California,) Tj
0 -12 Td
(which shall have exclusive  jurisdiction over such dispute.   1.4.2 In the event that the) Tj
0 -12 Td
(Chief Executive Officers are unable to resolve the dispute and the dispute has a monetary) Tj
0 -12 Td
(value of cost of less than  [**] dollars \($[**]\), and the Parties do not agree on the) Tj
0 -12 Td
(appointment of an expert to resolve the dispute, or mediation has failed to resolve  the) Tj
0 -12 Td
(dispute, one Party shall serve on the other a written Referral Notice requesting that the) Tj
0 -12 Td
(matter be referred to an expert for resolution,  and the following procedure shall be) Tj
0 -12 Td
(followed.) Tj
0 -12 Td
() Tj
0 -12 Td
(1.4.1 The dispute shall be determined by a single independent impartial expert who shall) Tj
0 -12 Td
(be agreed between the Parties or, in the  absence of agreement between the Parties within) Tj
0 -12 Td
(30 days of the service of a Referral Notice, be appointed by the American  Arbitration) Tj
0 -12 Td
(Association or any successor thereto, or such other competent body agreed by the Parties.) Tj
0 -12 Td
() Tj
0 -12 Td
(1.4.2 30 days after the appointment of the expert pursuant to paragraph 1.4.1 both Parties) Tj
0 -12 Td
(shall exchange simultaneously statements of  case in no more than 10,000 words, in total,) Tj
0 -12 Td
(and each side shall simultaneously send a copy of its statement of case to the expert.) Tj
0 -12 Td
ET
endstream
endobj
112 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 111 0 R >>
endobj
113 0 obj
<< /Length 3016 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
(1.4.3 Each Party may, within 30 days of the date of exchange of statement of case pursuant) Tj
0 -12 Td
(to paragraph 1.4.2, serve a reply to the  other side's statement of case in no more than) Tj
0 -12 Td
(10,000 words. A copy of any such reply shall be simultaneously sent to the expert.) Tj
0 -12 Td
() Tj
0 -12 Td
(1.4.4 Subject to paragraph 1.4.6, there shall be no oral hearing. The expert shall issue) Tj
0 -12 Td
(his decision in writing to both Parties within 30  days of the date of service of the last) Tj
0 -12 Td
(reply pursuant to paragraph 1.4.3 above or, in the absence of receipt of any replies,) Tj
0 -12 Td
(within  60 days of the date of exchange pursuant to paragraph 1.4.2.) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(-77-) Tj
0 -12 Td
() Tj
0 -12 Td
(1.4.5 The seat of the dispute resolution shall be the normal place of residence of the) Tj
0 -12 Td
(expert.) Tj
0 -12 Td
() Tj
0 -12 Td
(1.4.6 The expert shall not have power to alter, amend or add to the provisions of this) Tj
0 -12 Td
(Agreement, except that the expert shall have the  power to decide all procedural matters) Tj
0 -12 Td
(relating to the dispute, and may call for a one day hearing if desirable and appropriate.) Tj
0 -12 Td
() Tj
0 -12 Td
(1.4.7 The expert shall have the power to request copies of any documents in the possession) Tj
0 -12 Td
(and/or control of the Parties which may  be relevant to the dispute. The Parties shall) Tj
0 -12 Td
(forthwith provide to the expert and the other Party copies of any documents so  requested) Tj
0 -12 Td
(by the expert.) Tj
0 -12 Td
() Tj
0 -12 Td
(1.4.8 The decision of the expert shall be final and binding upon both Parties except in) Tj
0 -12 Td
(the case of manifest error. The Parties hereby  exclude any rights of application or) Tj
0 -12 Td
(appeal to any court, to the extent that they may validly so agree, and in particular in) Tj
0 -12 Td
(connection with any question of law arising in the course of the reference out of the) Tj
0 -12 Td
(award.) Tj
0 -12 Td
() Tj
0 -12 Td
(1.4.9 The expert shall determine the proportions in which the Parties shall pay the costs) Tj
0 -12 Td
(of the expert's procedure. The expert shall  have the authority to order that all or a) Tj
0 -12 Td
(part of the legal or other costs of a Party shall be paid by the other Party.) Tj
0 -12 Td
() Tj
0 -12 Td
(1.4.10 All documents and information disclosed in the course of the expert proceedings and) Tj
0 -12 Td
(the decision and award of the expert shall  be kept strictly confidential by the recipient) Tj
0 -12 Td
(and shall not be used by the recipient for any purpose except for the purposes of the) Tj
0 -12 Td
(proceedings and/or the enforcement of the expert's decision and award.) Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
114 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 113 0 R >>
endobj
115 0 obj
<< /Length 1742 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(SCHEDULE IX) Tj
0 -12 Td
() Tj
0 -12 Td
(SALES FORECAST) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(While we continue to work on our marketing plan and forecast, based on the current run) Tj
0 -12 Td
(rate of approximately [**] to [**] units per month, you  can expect that our plan will) Tj
0 -12 Td
(call for the following forecast:) Tj
0 -12 Td
() Tj
0 -12 Td
(-78-) Tj
0 -12 Td
() Tj
0 -12 Td
(Date: July 25, 2007   From: [**], EKR Therapeutics, Inc.   To: [**], Pacira   Re: DepoDur) Tj
0 -12 Td
(Unit Sales Forecast, as of July 25, 2007) Tj
0 -12 Td
() Tj
0 -12 Td
(Period) Tj
0 -12 Td
() Tj
0 -12 Td
(Unit  Sales  Forecast  August 1 - December 31, 2007     [**]  January 1 - December 31,) Tj
0 -12 Td
(2008     [**]  January 1 - December 31, 2009     [**]) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(SCHEDULE X) Tj
0 -12 Td
() Tj
0 -12 Td
(PHASE IV STUDIES) Tj
0 -12 Td
() Tj
0 -12 Td
(A DepoDur study in pediatric patients. Pacira has requested a waiver and is awaiting a) Tj
0 -12 Td
(response from the FDA      -79-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(SCHEDULE XI) Tj
0 -12 Td
() Tj
0 -12 Td
(NDA TRANSFER LETTERS) Tj
0 -12 Td
() Tj
0 -12 Td
(A. Transfer Letter to be Filed by PPI) Tj
0 -12 Td
() Tj
0 -12 Td
([PACIRA PHARMACEUTICALS, INC. LETTERHEAD]) Tj
0 -12 Td
() Tj
0 -12 Td
(, 2009) Tj
0 -12 Td
() Tj
0 -12 Td
(VIA OVERNIGHT MAIL) Tj
0 -12 Td
() Tj
0 -12 Td
([NAME AND ADDRESS OF APPROPRIATE FDA CONTACT TO BE PROVIDED]) Tj
0 -12 Td
() Tj
0 -12 Td
(General Correspondence: Transfer of NDA Ownership) Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
116 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 115 0 R >>
endobj
117 0 obj
<< /Length 2624 >>
stream
BT
/F1 10 Tf
72 720 Td
(Dear  :) Tj
0 -12 Td
() Tj
0 -12 Td
(Effective  , 2009, pursuant to 21 CFR 314.72, DepoDur  NDA [**] is hereby transferred from) Tj
0 -12 Td
(Pacira Pharmaceuticals, Inc. to EKR Therapeutics, Inc.,  1545 Route 206 South, Third) Tj
0 -12 Td
(Floor, Bedminster, New Jersey 07921 \(Regulatory Contact:  , telephone  \).) Tj
0 -12 Td
() Tj
0 -12 Td
(As a condition of this transfer of ownership, Pacira will provide to EKR Therapeutics all) Tj
0 -12 Td
(available information pertaining to the above-referenced  NDA to be kept under 21 CFR) Tj
0 -12 Td
(314.70, including all previous correspondence to and from the Agency. A signed 356h form) Tj
0 -12 Td
(is attached) Tj
0 -12 Td
() Tj
0 -12 Td
(If you have any questions or require any additional information, please do not hesitate to) Tj
0 -12 Td
(contact me at  .) Tj
0 -12 Td
() Tj
0 -12 Td
(Sincerely,) Tj
0 -12 Td
() Tj
0 -12 Td
(PACIRA PHARMACEUTICALS, INC.      -80-) Tj
0 -12 Td
() Tj
0 -12 Td
(Re: DepoDur  NDA [**]) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(B. Transfer Letter to be Filed by EKR) Tj
0 -12 Td
() Tj
0 -12 Td
([EKR THERAPEUTICS, INC. LETTERHEAD]) Tj
0 -12 Td
() Tj
0 -12 Td
(, 2009) Tj
0 -12 Td
() Tj
0 -12 Td
(VIA OVERNIGHT MAIL) Tj
0 -12 Td
() Tj
0 -12 Td
([NAME AND ADDRESS OF APPROPRIATE FDA CONTACT TO BE PROVIDED]) Tj
0 -12 Td
() Tj
0 -12 Td
(DepoDur    General Correspondence: Transfer of NDA Ownership) Tj
0 -12 Td
() Tj
0 -12 Td
(Dear  :) Tj
0 -12 Td
() Tj
0 -12 Td
(Pursuant to 21 CFR 314.72 the above-mentioned NDA has been transferred from Pacira) Tj
0 -12 Td
(Pharmaceuticals, Inc. to EKR Therapeutics, Inc.  effective  , 2009. EKR has received a) Tj
0 -12 Td
(complete copy of the approved application, including all supplements and records that are) Tj
0 -12 Td
(required to be kept  under 21 CFR 314.81. EKR agrees to abide by all agreements, promises) Tj
0 -12 Td
(and conditions made by the former owner, which are contained in the  application. EKR will) Tj
0 -12 Td
(advise the FDA about any changes in the conditions in the approved application as required) Tj
0 -12 Td
(by 21 CFR 314.70, or in the next  annual report, if appropriate. EKR will consider the) Tj
0 -12 Td
(date of transfer to be the new date for annual reporting purposes. A new signed 356h form) Tj
0 -12 Td
(is  attached.) Tj
0 -12 Td
() Tj
0 -12 Td
(Please contact me by phone at  , by email at   or by fax at  , if you have any questions) Tj
0 -12 Td
(or if you require additional information.) Tj
0 -12 Td
() Tj
0 -12 Td
(-81-) Tj
0 -12 Td
() Tj
0 -12 Td
ET
endstream
endobj
118 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 117 0 R >>
endobj
119 0 obj
<< /Length 2137 >>
stream
BT
/F1 10 Tf
72 720 Td
(RE: NDA No. [**]) Tj
0 -12 Td
() Tj
0 -12 Td
(Sincerely,) Tj
0 -12 Td
() Tj
0 -12 Td
([Name / Title]) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(SCHEDULE XII) Tj
0 -12 Td
() Tj
0 -12 Td
(TRANSFERRED EQUIPMENT) Tj
0 -12 Td
() Tj
0 -12 Td
(DepoDur processing equipment:) Tj
0 -12 Td
() Tj
0 -12 Td
(1. ST-01 \([**], [**] rated to [**], equipped with agitator used in preparation of [**]) Tj
0 -12 Td
(prior to [**]\)) Tj
0 -12 Td
() Tj
0 -12 Td
(2. ST-02 \([**], [**] rated to [**], equipped with agitator used in preparation of [**]) Tj
0 -12 Td
([**] prior to [**]\)) Tj
0 -12 Td
() Tj
0 -12 Td
(3. ST-03 \([**], [**] rated to [**], equipped with agitator used in preparation of [**]) Tj
0 -12 Td
(prior to [**]\)) Tj
0 -12 Td
() Tj
0 -12 Td
(4. ST-04 \([**], [**] rated to [**], equipped with agitator used in preparation of [**]) Tj
0 -12 Td
([**] prior to [**]\)) Tj
0 -12 Td
() Tj
0 -12 Td
(5. ST-22 \([**], [**] rated to [**], [**]\)) Tj
0 -12 Td
() Tj
0 -12 Td
(6. EV-01 \([**], [**] rated to [**], equipped with [**] used to produce [**] [**]\)) Tj
0 -12 Td
() Tj
0 -12 Td
(7. EV-02 \([**], [**] rated to [**], equipped with [**] and [**] [**] used to produce [**]\)) Tj
0 -12 Td
() Tj
0 -12 Td
(8. FV-01 \([**], [**] rated to [**], used [**] during [**]\)) Tj
0 -12 Td
() Tj
0 -12 Td
(9. [**] skid, including [**] lobe pumps, [**] manifold system, and [**] flometers) Tj
0 -12 Td
() Tj
0 -12 Td
(10. Interconnective valves and piping between vessels) Tj
0 -12 Td
() Tj
0 -12 Td
(11. Pressure gauges, temperature probes, other small instrumentation for in-process) Tj
0 -12 Td
(measurements.) Tj
0 -12 Td
() Tj
0 -12 Td
(12. HMI / PLC / automation      -82-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Exhibit 3.20\(a\)   Form of Bill of Sale) Tj
0 -12 Td
() Tj
0 -12 Td
(BILL OF SALE) Tj
0 -12 Td
() Tj
0 -12 Td
(THIS BILL OF SALE, dated October  , 2009 \(this "Bill of Sale"\), is made by Pacira) Tj
0 -12 Td
(Pharmaceuticals, Inc. \("Seller"\), in favor of EKR  Therapeutics, Inc. \("Purchaser"\).) Tj
0 -12 Td
ET
endstream
endobj
120 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 119 0 R >>
endobj
121 0 obj
<< /Length 3771 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
(WHEREAS, Purchaser and Seller have entered into that certain Amended and Restated) Tj
0 -12 Td
(Strategic Licensing, Distribution and Marketing  Agreement, dated as of the date hereof) Tj
0 -12 Td
(\(the "Agreement"\), providing, among other things, for the sale of the Transferred) Tj
0 -12 Td
(Equipment \(as defined  therein\) by Seller to Purchaser.) Tj
0 -12 Td
() Tj
0 -12 Td
(NOW, THEREFORE, for good and valuable consideration, the receipt of which is hereby) Tj
0 -12 Td
(acknowledged, Seller and Purchaser agree as  follows:) Tj
0 -12 Td
() Tj
0 -12 Td
(1. Definitions. Capitalized terms used in this Bill of Sale and not otherwise defined in) Tj
0 -12 Td
(this Bill of Sale shall have the respective meanings assigned  to them in the Agreement.) Tj
0 -12 Td
() Tj
0 -12 Td
(2. Conveyance. In accordance with the terms of the Agreement, Seller hereby sells,) Tj
0 -12 Td
(transfers, conveys and assigns to Purchaser all right, title and  interest in and to the) Tj
0 -12 Td
(Transferred Equipment. A list of the Transferred Equipment is set forth on Schedule A to) Tj
0 -12 Td
(this Bill of Sale.) Tj
0 -12 Td
() Tj
0 -12 Td
(3. Further Assurances. At any time and from time to time after the date of this Bill of) Tj
0 -12 Td
(Sale, Seller, at the Purchaser's request and subject to  reimbursement by Purchaser of any) Tj
0 -12 Td
(out-of-pocket expenses, will do, execute, acknowledge and deliver, or will cause to be) Tj
0 -12 Td
(done, executed,  acknowledged and delivered, any and all further acts, conveyances,) Tj
0 -12 Td
(transfers, assignments and assurances as may be reasonably required by  Purchaser to) Tj
0 -12 Td
(further evidence and effectuate the sale, transfer, conveyance and assignment to the) Tj
0 -12 Td
(Purchaser of the Transferred Equipment.) Tj
0 -12 Td
() Tj
0 -12 Td
(4. Relationship With Agreement. The provisions of this Bill of Sale are subject, in all) Tj
0 -12 Td
(respects, to the terms and conditions of the Agreement and  all of the representations,) Tj
0 -12 Td
(warranties, covenants and agreements contained in the Agreement. Nothing contained in this) Tj
0 -12 Td
(Bill of Sale shall be  deemed to modify, limit or amend any such rights and obligations of) Tj
0 -12 Td
(the parties hereto under the Agreement. In the event of any conflict or  inconsistency) Tj
0 -12 Td
(between this Bill of Sale and the Agreement, the Agreement shall govern.) Tj
0 -12 Td
() Tj
0 -12 Td
(5. Successors and Assigns. This Bill of Sale shall be binding upon and inure to the) Tj
0 -12 Td
(benefit of and be enforceable by Seller and Purchaser and their  respective successors and) Tj
0 -12 Td
(assigns.) Tj
0 -12 Td
() Tj
0 -12 Td
(6. Governing Law. This Bill of Sale shall be governed by, and construed in accordance) Tj
0 -12 Td
(with, the laws of the State of New York, without regard to  the conflicts of law) Tj
0 -12 Td
(principles thereof.) Tj
0 -12 Td
() Tj
0 -12 Td
(7. Counterparts; Facsimile Signature Pages. This Bill of Sale may be executed by each of) Tj
0 -12 Td
(Seller and Purchaser in separate counterparts, each of  which when so executed and) Tj
0 -12 Td
(delivered shall be deemed to be an original and which together shall constitute one and) Tj
0 -12 Td
(the same instrument. Any  signed counterpart of this Bill of Sale which is delivered by) Tj
0 -12 Td
(facsimile or other printable electronic transmission shall be deemed to be executed and) Tj
0 -12 Td
(delivered for all purposes.) Tj
0 -12 Td
() Tj
0 -12 Td
([Signature Page Follows]      -83-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(IN WITNESS WHEREOF, Seller has executed and delivered this Bill of Sale on the date first) Tj
0 -12 Td
(above written.) Tj
0 -12 Td
ET
endstream
endobj
122 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 121 0 R >>
endobj
123 0 obj
<< /Length 2122 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
(Acknowledged and Agreed to as   of the date first above written.) Tj
0 -12 Td
() Tj
0 -12 Td
(-84-) Tj
0 -12 Td
() Tj
0 -12 Td
(Pacira Pharmaceuticals, Inc.) Tj
0 -12 Td
() Tj
0 -12 Td
(By:     Print Name:     Title:) Tj
0 -12 Td
() Tj
0 -12 Td
(EKR Therapeutics, Inc.) Tj
0 -12 Td
() Tj
0 -12 Td
(By:     Print Name:     Title:) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Schedule A to Bill of Sale   Transferred Equipment) Tj
0 -12 Td
() Tj
0 -12 Td
(DepoDur processing equipment:) Tj
0 -12 Td
() Tj
0 -12 Td
(1. ST-01 \([**], [**] rated to [**], equipped with agitator used in preparation of [**]) Tj
0 -12 Td
(prior to [**]\)) Tj
0 -12 Td
() Tj
0 -12 Td
(2. ST-02 \([**], [**] rated to [**], equipped with agitator used in preparation of [**]) Tj
0 -12 Td
([**] prior to [**]\)) Tj
0 -12 Td
() Tj
0 -12 Td
(3. ST-03 \([**], [**] rated to [**], equipped with agitator used in preparation of [**]) Tj
0 -12 Td
(prior to [**]\)) Tj
0 -12 Td
() Tj
0 -12 Td
(4. ST-04 \([**], [**] rated to [**], equipped with agitator used in preparation of [**]) Tj
0 -12 Td
([**] prior to [**]\)) Tj
0 -12 Td
() Tj
0 -12 Td
(5. ST-22 \([**] [**], [**] rated to [**], [**] [**]\)) Tj
0 -12 Td
() Tj
0 -12 Td
(6. EV-01 \([**], [**] rated to [**], equipped with [**] used to produce [**] [**]\)) Tj
0 -12 Td
() Tj
0 -12 Td
(7. EV-02 \([**], [**] rated to [**], equipped with [**] and [**] [**] used to produce [**]\)) Tj
0 -12 Td
() Tj
0 -12 Td
(8. FV-01 \([**], [**] rated to [**], used [**] during [**]\)) Tj
0 -12 Td
() Tj
0 -12 Td
(9. [**] skid, including [**] lobe pumps, [**] manifold system, and [**] flometers) Tj
0 -12 Td
() Tj
0 -12 Td
(10. Interconnective valves and piping between vessels) Tj
0 -12 Td
() Tj
0 -12 Td
(11. Pressure gauges, temperature probes, other small instrumentation for in-process) Tj
0 -12 Td
(measurements.) Tj
0 -12 Td
() Tj
0 -12 Td
(12. HMI / PLC / automation      -85-) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(Exhibit 3.20\(b\)   Form of Promissory Note) Tj
0 -12 Td
ET
endstream
endobj
124 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 123 0 R >>
endobj
125 0 obj
<< /Length 4029 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
(PROMISSORY NOTE) Tj
0 -12 Td
() Tj
0 -12 Td
(FOR VALUE RECEIVED, EKR Therapeutics, Inc. \("Maker"\), having an address at 1545 Route 206) Tj
0 -12 Td
(South, Third Floor, Bedminster,  New Jersey 07921, hereby promises to pay to Pacira) Tj
0 -12 Td
(Pharmaceuticals, Inc. \("Payee"\), having an address at 10450 Sciences Center Drive, San) Tj
0 -12 Td
(Diego,  California 92121, the principal sum of NINE HUNDRED THOUSAND DOLLARS) Tj
0 -12 Td
(\($900,000.00\), plus interest computed at the rate of FIVE PERCENT \(5%\) per annum, in) Tj
0 -12 Td
(accordance with the terms and conditions set forth in this Promissory Note \(this "Note"\).) Tj
0 -12 Td
() Tj
0 -12 Td
(1. Payments. On the fifth anniversary of the date of this Note, all principal and interest) Tj
0 -12 Td
(\(calculated according to Paragraph 3 below\)  accrued on this Note and not sooner paid in) Tj
0 -12 Td
(accordance with the terms hereof shall be payable in full \(the "Payment"\).) Tj
0 -12 Td
() Tj
0 -12 Td
(2. Place of Payment. The entire amount due hereunder shall be payable to Payee at the) Tj
0 -12 Td
(address set forth above, or at such other place  as Payee may designate in writing to) Tj
0 -12 Td
(Maker at the address set forth above.) Tj
0 -12 Td
() Tj
0 -12 Td
(3. Interest Calculation: Interest shall be calculated on the basis of a 360 day year based) Tj
0 -12 Td
(on the number of days elapsed.) Tj
0 -12 Td
() Tj
0 -12 Td
(4. Optional Prepayment. Maker may, at its option, prepay the entire amount due hereunder) Tj
0 -12 Td
(in whole at any time or in part from time to  time without penalty or premium. At the) Tj
0 -12 Td
(option of Maker, prepayments pursuant to this Paragraph 4 shall \(a\) be applied to the) Tj
0 -12 Td
(outstanding  principal balance in reverse order of maturity or \(b\) reduce the Payment) Tj
0 -12 Td
(installments set forth above for the balance of the term of this Note. In the  event that) Tj
0 -12 Td
(Maker elects to reduce the Payment installments, Maker agrees to provide to Payee written) Tj
0 -12 Td
(notice of its election to do so at least thirty  \(30\) days prior to making any prepayment) Tj
0 -12 Td
(and to execute and deliver to Payee an amendment to this Note setting forth a revised) Tj
0 -12 Td
(payment  schedule.) Tj
0 -12 Td
() Tj
0 -12 Td
(5. Defaults. At the option of Payee, the entire amount due hereunder shall immediately) Tj
0 -12 Td
(become due and payable on any of the  following events of default:   \(a\) Maker fails to) Tj
0 -12 Td
(make Payment as provided for in this Note and such failure to make Payment continues for) Tj
0 -12 Td
(thirty \(30\) days after  Maker's receipt of written notice from Payee that such Payment is) Tj
0 -12 Td
(due;   \(b\) Maker makes a general assignment for the benefit of creditors;      -86-) Tj
0 -12 Td
() Tj
0 -12 Td
($900,000   October  , 2009) Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
() Tj
0 -12 Td
(\(c\) A receiver is appointed for the assets of Maker upon request by any Person\(s\) other) Tj
0 -12 Td
(than Maker, or Maker makes a formal  request for appointment of a receiver; or   \(d\) Any) Tj
0 -12 Td
(proceeding is brought by Maker in any court or under supervision of any court-appointed) Tj
0 -12 Td
(officer under any federal or  state bankruptcy, reorganization, rearrangement, insolvency) Tj
0 -12 Td
(or debt readjustment law, or if any such proceedings are instituted against  Maker and) Tj
0 -12 Td
(Maker fails to obtain dismissal of such proceeding within ninety \(90\) days after the same) Tj
0 -12 Td
(has been instituted.) Tj
0 -12 Td
() Tj
0 -12 Td
(6. Agreement. This Note is made pursuant to that certain Amended and Restated Strategic) Tj
0 -12 Td
(Licensing, Distribution and Marketing  Agreement dated as of October  , 2009 by and) Tj
0 -12 Td
(between Maker and Payee \(the "Agreement"\)  and is subject to the terms thereof. This Note) Tj
0 -12 Td
(is  subject to offset as expressly provided for in the Agreement.) Tj
0 -12 Td
ET
endstream
endobj
126 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 125 0 R >>
endobj
127 0 obj
<< /Length 772 >>
stream
BT
/F1 10 Tf
72 720 Td
() Tj
0 -12 Td
(7. Nonnegotiability, Nontransferability. This Note shall be nonnegotiable. Further, this) Tj
0 -12 Td
(Note may not be transferred by either party  except to a permitted transferee under the) Tj
0 -12 Td
(Agreement.) Tj
0 -12 Td
() Tj
0 -12 Td
(8. Governing Law. This Note shall be governed by and construed in accordance with the laws) Tj
0 -12 Td
(of the State of New York, excluding any  conflict-of-laws rule or principle that may refer) Tj
0 -12 Td
(the governance, construction or interpretation of this Note to the laws of another State.) Tj
0 -12 Td
() Tj
0 -12 Td
(IN WITNESS WHEREOF, the Maker has executed this promissory note as of  .) Tj
0 -12 Td
() Tj
0 -12 Td
(-87-) Tj
0 -12 Td
() Tj
0 -12 Td
(, Maker) Tj
0 -12 Td
ET
endstream
endobj
128 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Resources << /Font << /F1 129 0 R >> >> /Contents 127 0 R >>
endobj
129 0 obj
<< /Type /Font /Subtype /Type1 /BaseFont /Helvetica >>
endobj
xref
0 130
0000000000 65535 f 
0000000009 00000 n 
0000000058 00000 n 
0000000565 00000 n 
0000003706 00000 n 
0000003834 00000 n 
0000006650 00000 n 
0000006778 00000 n 
0000009507 00000 n 
0000009635 00000 n 
0000012236 00000 n 
0000012365 00000 n 
0000015141 00000 n 
0000015271 00000 n 
0000018398 00000 n 
0000018528 00000 n 
0000020966 00000 n 
0000021096 00000 n 
0000024201 00000 n 
0000024331 00000 n 
0000028412 00000 n 
0000028542 00000 n 
0000032515 00000 n 
0000032645 00000 n 
0000035928 00000 n 
0000036058 00000 n 
0000040213 00000 n 
0000040343 00000 n 
0000043381 00000 n 
0000043511 00000 n 
0000047006 00000 n 
0000047136 00000 n 
0000050412 00000 n 
0000050542 00000 n 
0000054022 00000 n 
0000054152 00000 n 
0000057744 00000 n 
0000057874 00000 n 
0000061715 00000 n 
0000061845 00000 n 
0000065704 00000 n 
0000065834 00000 n 
0000069172 00000 n 
0000069302 00000 n 
0000072328 00000 n 
0000072458 00000 n 
0000076477 00000 n 
0000076607 00000 n 
0000079096 00000 n 
0000079226 00000 n 
0000082300 00000 n 
0000082430 00000 n 
0000086448 00000 n 
0000086578 00000 n 
0000089486 00000 n 
0000089616 00000 n 
0000092761 00000 n 
0000092891 00000 n 
0000097002 00000 n 
0000097132 00000 n 
0000100303 00000 n 
0000100433 00000 n 
0000103129 00000 n 
0000103259 00000 n 
0000105920 00000 n 
0000106050 00000 n 
0000108849 00000 n 
0000108979 00000 n 
0000111412 00000 n 
0000111542 00000 n 
0000115604 00000 n 
0000115734 00000 n 
0000119265 00000 n 
0000119395 00000 n 
0000122667 00000 n 
0000122797 00000 n 
0000126677 00000 n 
0000126807 00000 n 
0000130378 00000 n 
0000130508 00000 n 
0000133727 00000 n 
0000133857 00000 n 
0000136495 00000 n 
0000136625 00000 n 
0000139662 00000 n 
0000139792 00000 n 
0000143325 00000 n 
0000143455 00000 n 
0000147192 00000 n 
0000147322 00000 n 
0000150626 00000 n 
0000150756 00000 n 
0000154441 00000 n 
0000154571 00000 n 
0000156779 00000 n 
0000156909 00000 n 
0000160302 00000 n 
0000160432 00000 n 
0000163723 00000 n 
0000163853 00000 n 
0000167214 00000 n 
0000167345 00000 n 
0000170442 00000 n 
0000170574 00000 n 
0000173011 00000 n 
0000173143 00000 n 
0000174523 00000 n 
0000174655 00000 n 
0000178571 00000 n 
0000178703 00000 n 
0000182263 00000 n 
0000182395 00000 n 
0000185471 00000 n 
0000185603 00000 n 
0000188673 00000 n 
0000188805 00000 n 
0000190601 00000 n 
0000190733 00000 n 
0000193411 00000 n 
0000193543 00000 n 
0000195734 00000 n 
0000195866 00000 n 
0000199691 00000 n 
0000199823 00000 n 
0000201999 00000 n 
0000202131 00000 n 
0000206214 00000 n 
0000206346 00000 n 
0000207171 00000 n 
0000207303 00000 n 
trailer << /Size 130 /Root 1 0 R >>
startxref
207375
%%EOF
